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Guest editor’s preface
The author
Professor C. E. Rossiter was Professor of Occupational Health, University of
London between 1984-1989, and is now Emeritus Professor of Occupational
Health.
He has specialised in the epidemiological study of the health risks of exposure
to airborne fibres, for most of his academic career. When the Joint European
Medical Research Board (JEMRB) was founded in 1975 to fund research into the
health effects of the insulation wools, he was appointed Secretary of the Scientific
and Technical Committee advising that Board. He has been Chairman of JEMRB
since 1988.
Professor Rossiter was honoured with the Freedom of the City of London in
1988.
The report
This report is a tale of the development of the epidemiological evidence base in
risk assessments with respect to workplace exposure to Man Made Vitreous
Fibres. The author reviews the recent three decades of occupational health history
during which time the knowledge base has expanded and become strengthened
through the efforts of research groups in many countries.
It is an important report. Epidemiological studies, when designed and executed
with scientific rigour, provide heavyweight evidence in assessments of toxic
properties of hazardous agents. The author has, through his affiliation as scientific
advisor to the industrial body Joint European Medical Research Board (JEMRB)
had close contacts with scientific projects and researchers around the world
addressing the issues reviewed in this report.
The author leads the reader from the starting point of epidemiological studies
in the early 1970’s following it up scrutinizing the language used by the re-
searchers in their reports over the years in their pursuit of evidence corroboration.
This follow-up is brought to a conclusion with the International Agency for
Research on Cancer (IARC) evaluation of the carcinogenicity of MMVF in 2002.
In this evaluation by the IARC fibres of insulation glass wool, continuous glass
filament fibres and rock- and slagwool fibres were declared as ”not classifiable as
to carcinogenicity to humans” marking an important reappraisal of previously
made assessments of these materials.
It is a fascinating narrative, in its adherence to a time scale, starting with the
incentives setting research efforts in motion in many European countries and also
in the US and Canada. The reader is taken along with the author to explore and
examine the evidence as it unfolds and to follow the research groups use of all
their ingenuity to find out ways to corroborate their previous findings in changing
study designs and methods and in using new sources of information.
The basic study hypothesis was all along that workplace exposure to mineral
fibres implies risk for cancer disease. This was based on a model of analogy with
asbestos fibres. Asbestos was at the time, and is still, a natural basis of comparison
in assessing toxic properties of fibres taking into account the well-known
carcinogenic potentials of most asbestos fibres.
This report describes the efforts of the researchers to bring out the facts of the
case. There is an element of an antique drama in this report, with events and inter-
pretations developing over the time course. This also implies the monitoring of the
researchers’ use of language to frame their assessments of the balance of
probabilities and uncertainties with regard to the MMVF as potential determinant
of cancer risk. It has all the time as been necessary to remind of other possible
explanations than MMVF exposure for the lung cancer incidences observed.
This is not only a report on the carcinogenic properties of a few specified types
of MMVF fibres. It is also the narrative of how research groups in many countries
of the world, in all their ingenuity resilience, in pursuit of a truly valid result
position themselves in relation to new results. It is a tale of hard work, hard
thinking and – more often than not – the search for new solutions to new prob-
lems, not stopping with work only half-done.
Peter Westerholm, MD FFOM, Professor Emeritus
National Institute for Working Life
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11. The Research Trigger
This story starts a century ago. In 1901, Montague Murray recorded the death
from lung fibrosis of a 33-year-old man who had worked in an asbestos carding
mill for ten years. This he presented in 1907, as resulting from exposure to
asbestos dust (HM Murray, 1907). By 1931, following several other reports (eg
Merewether & Price, 1930), lung fibrosis resulting from exposure to asbestos had
been named “asbestosis” and the first studies of working conditions in asbestos
textile factories had been undertaken. These led to the British Government
recognising the adverse effects of asbestos exposure, and the promulgation of the
1931 Asbestos Industry Regulations requiring dust suppression measures
(Government of the United Kingdom, 1931).
Just as there were some two decades from the earliest published reports to the
general acceptance that asbestos exposure caused lung fibrosis, so it was many
years from the first hints to the broad acceptance that lung cancer could also be
caused by such exposure. Prompted by the occasional case reports and a review
by the UK Factory Inspectorate, the first epidemiological study was undertaken by
Doll (1955) showing that workers with 20 or more years of exposure to asbestos
dust had a ten-fold increased risk of lung cancer. This evidence of carcinogenic
risk was strongly supported by the findings of marked excess of lung cancer
among American insulation workers (Selikoff et al, 1965).
Early reports of mesothelioma cases were rather more quickly followed by
confirmation. Wagner et al (1960) reported 33 cases of mesothelioma occurring in
four years associated with crocidolite exposure in South Africa. This study was
doubly important in that it showed that mesothelioma cases also occurred among
those who lived near the crocidolite mines and processing mills.
In 1964, the UICC Working Group on Asbestos and Cancer (1965) recom-
mended that epidemiological investigations should be conducted to determine the
importance of asbestos fibre type on the risk of mesothelioma, lung cancer,
fibrosis, and other cancers. This confirmed a general acceptance that asbestos-
exposure could cause these conditions, but emphasized the need for further under-
standing.
For a full discussion of the above history, see for example Government of
Ontario (1984) or Selikoff and Lee (1978). An IARC Working Group evaluation
of Asbestos hazard (IARC, 1977) reviewed the human and experimental evidence
up to 1976.
The turning point for extending the range of fibres of concern beyond asbestos
occurred in 1972 with the publication of two experimental reports (Stanton &
Wrench, 1972; Pott & Friedrichs, 1972). In the first of a series of studies, Stanton
and Wrench used intra-pleural implantation of various asbestos fibres and fibrous
glass to investigate mesothelioma induction. The results indicated that increased
carcinogenicity of asbestos and fibrous glass was related to greater fibre length,
finer diameter and higher length/diameter ratio rather than to the physicochemical
2properties of the fibres. Pott and Friedrichs used intra-peritoneal injection, also of
a range of fibres, including glass fibres. They reached a similar conclusion to
Stanton and Wrench.
Interestingly, in further experiments, both research teams argued that durability
of the fibres was important, in addition to fibrous shape and size. Stanton et al
(1977) commented
“Since neoplastic response to a variety of types of durable fibers, particu-
larly asbestos fibers, was similar, our experiments reinforce the idea that the
carcinogenicity of fibers depends on dimension and durability rather than
physicochemical properties and emphasize that all respirable fibers be
viewed with caution.”
Pott et al (1976) had also reached a similar conclusion that a requirement for
carcinogenic potential in the peritoneal cavity was that the fibres were insoluble
there.
But this is taking us ahead in this history.
1.1 Asbestos and man-made vitreous fibres
Today, there is a general international consensus that the adverse health effects of
respirable fibres are primarily related to three factors, often termed the three Ds:
• Dose: the amount of respirable airborne fibres to which people are exposed;
• Dimensions: the size of the airborne fibres, which governs how easily fibres
may be inhaled, where they may be deposited in the lungs and the mechanisms
by which they can be removed from the lungs;
•  Durability: better termed “Biopersistence”, that is, how long inhaled and
deposited fibres will be retained in the lung.
Airborne fibres are unique in that they are the only airborne particles which can be
inhaled but which may be too long for clearance by macrophages, the primary
deep-lung clearance mechanism. The critical fibre size is longer than about 15 µm
and finer than about 1 µm. Thus, fibres longer than those that can be engulfed by
macrophages can only clear by dissolution or by transverse fracture into shorter
pieces. This fracture, if it occurs, is only likely if there has been significant
dissolution of the fibre. Fracture is much less likely for asbestos fibres, than for
the man-made vitreous fibres (MMVFs). Asbestos fibres are crystalline, and tend
to split longitudinally creating finer fibres, whereas MMVF1 are amorphous, and
cannot split longitudinally.
The fibres of most concern are those that are sufficiently durable to remain in
the lungs for a sufficient period of time, are fine enough to enter the lungs in the
                                    
1 Throughout this report I refer to “man-made vitreous fibres (MMVF)”, the most
commonly used term today. originally, “man-made mineral fibres (MMMF)” was in
common use; “synthetic vitreous fibres (SVF)” is also used, particularly in Austral-
asia.
3first place, and are present in a high enough dose: erionite and crocidolite (blue)
asbestos. Both these fibre types are very fine, with the majority of airborne fibres
less than 0.2 µm in diameter. Such fibres can be inhaled easily, deposited readily
in the lung, and are very biopersistent. In use, asbestos exposure levels have often
been higher than 100 f.ml-1, and exposures have been reported above 1,000 f.ml-1
(NIOSH, 1976; Harries, 1971). Erionite exposures, such as those which occurred
at Karain, Turkey, were rather lower, but this environmental exposure was conti-
nuous, effectively increasing the dose. For these fibre types (and for amosite and
chrysotile asbestos), there is clear human evidence of the causation of the other
three Ds: Disability, Disease and Death, from mesothelioma, lung cancer and lung
fibrosis (IARC, 1977).
Airborne asbestos fibres are rather short, but studies from the Institute of
Occupational Medicine (Cullen et al, 2000; Davis et al, 1986) have shown that
there are enough long fibres present for there to be free non-soluble fibres in the
lung tissue available to cause lung damage. There may be additional cytotoxicity
enhancing the adverse effects of these fibre types.
At the other end of this continuum of mineral fibres come the MMVF. The
term MMVF includes the insulation wools (fibre glass, stone [rock] wool, slag
wool), refractory ceramic fibres and some speciality glass fibres. Some exposures
to refractory ceramic fibres have been recorded up to about 20 f.ml-1, but that is an
uncommon occurrence. Occupational exposures to fibre glass, stone and slag wool
have rarely exceeded about 5 f.ml-1 under the dustiest conditions (IARC, 1988).
The fibre diameters of most MMVF are much larger than those of asbestos
fibres, with few MMVF less than 1 µm and virtually none less than 0.2 µm in
diameter. However, airborne respirable MMVF can be much longer than asbestos
fibres. The other major difference between asbestos fibres and MMVF is in their
biopersistence. For example, Hesterberg et al (1996, 1998) compared, by in-
halation, the biopersistence of crocidolite, amosite and several MMVFs. One year
after the end of exposure, 17 per cent of the crocidolite fibres and 70 per cent of
the amosite fibres longer than 20 µm had been cleared from the rat lungs. For the
most biopersistent MMVF, 90-95 per cent of long fibres had been cleared and for
the least biopersistent, most soluble fibre types, more than 99 per cent of long
fibres were cleared.
1.2 Initial research programme on MMVF
The research reports by Stanton and Wrench, and Pott and Friedrichs in 1972
triggered the European and American insulation wool trade associations to con-
sider what research should be supported following the findings of carcinogenicity
of fibres implanted or injected into the pleural and peritoneal cavities of rats. The
trade associations required that supported research should be carried out by inde-
pendent research teams, with publication expected in the peer-reviewed literature.
In late 1975, EURIMA (European Insulation Manufacturers Association) and
CIRFS (Comité International de la Rayonne et des Fibres Synthétiques) agreed to
cooperate in a research programme. They created the Joint European Medical
4Research Board (JEMRB). This is an English charity advising the industry and
sponsoring relevant research. The initial sponsorship was for a cohort mortality
study of production workers, for industrial hygiene studies, and for animal
experimental research (Cameron, 1977). At the same time in USA, TIMA (Ther-
mal Insulation Manufacturers Association of America) initiated a similar spon-
sored research programme.
In Europe, the epidemiological studies were undertaken at the International
Agency for Research on Cancer, Lyon, France (IARC) with the associated
industrial hygiene being carried out by the Institute of Occupational Medicine,
Edinburgh (IOM). The epidemiological research in USA was undertaken at the
University of Pittsburgh, in the Department of Biostatistics and the Center for
Environmental Epidemiology. The industrial hygiene programme was also
conducted in the same University, in the Department of Industrial and Environ-
mental Health Sciences.
These studies initially included around 22,000 production workers in the
European study, and 17,000 in the American study. These are among the larger
cohort studies ever undertaken. There are some differences between these two
studies, of which the reader should be aware. The European study included
production workers in most factories who had had less than one-year of
employment. In the American study, the lower employment limit was one-year in
15 factories, and six months in the other two. The American term “mineral wool”
is equivalent to the previous European term “rock/slag wool” and the current term
“stone/slag wool”. The European study concentrated on lung cancer, whereas the
American study considered respiratory system cancer, which is typically about
four per cent higher.
There have been no published mortality or cancer incidence studies of
refractory ceramic fibre workers, in production or use, so this group of MMVF is
not considered further in this review.
2. The Years from 1975 to 1987
2.1 First WHO European Office Workshop on MMVF
An early initiative by JEMRB was the sponsorship of a Workshop at the WHO
Regional Office for Europe in October 1976. This workshop (WHO Regional
Office for Europe, 1977) considered the then present knowledge and research on
the biological effects of exposure to man made vitreous fibres (MMVF).
At this time, the consensus was that there was very little evidence of adverse
health effects of occupational exposure to MMVF (other than transient mechani-
cal skin irritation), although the intra-cavitary studies published four years earlier
did raise questions needing resolution (Gilson, 1977). In discussion, the pro-
duction industry was described as “an industry searching for a problem”.
52.2 Second WHO European Office Symposium on MMVF
But the picture was changing. At the second WHO meeting in 1982, evidence was
presented of a small excess of lung cancer among production workers with more
than 30 years since first employment. Workers producing stone/slag wool had a
greater excess than those producing glass fibres in both the major European and
American mortality studies, but the pattern of excess lung cancer did not appear to
be related to length or intensity of exposure (Enterline & Marsh, 1984; Saracci et
al, 1984).
For example, Table 1 presents the lung cancer mortality analysis for the
follow-up to 1977–1979 (dependent on country) from the European study (Saracci
et al, 1984) sub-divided by type of fibre produced. For each type of fibre, the
SMR was highest for those with 30 or more years since first employment,
although none of the SMRs was statistically significant at the conventional five
per cent significance level. Unlike the extended follow-up investigations, this first
study only determined the SMRs by reference to the national populations.
“Years since first employment” has been used in most of these epidemiological
studies as a surrogate for exposure, as no individual estimates of exposure to
respirable fibres have been available. In these early years, estimates of airborne
respirable fibres could be determined for the various production areas in each
factory, but not assigned to the individual workers as the employment records
were inadequate for epidemiological purposes. “Duration of employment” has
also been used, but the research teams have generally preferred “years since first
employment” as the primary surrogate measure. Where relevant, this review has
used this latter index.
However, any index based solely on time cannot provide any differentiation in
response related to exposure to respirable fibres. The most recent studies,
discussed in sections 4.1 and 4.2, have included assessments of fibre exposure for
individual workers.
Table 1. European Cohort Study: mortality analysis up to 1977-1979. Deaths from cancer
of the trachea, bronchus and lung, SMRs, and 95% confidence intervals. (Males only.
Expected deaths based on national reference populations.)
Years since first employment
Production <20 years 20–29 years 30 + years Total
Glass wool
Deaths
SMR
95% ci
30
96
65–137
10
76
37–140
4
157
43–402
44
94
68–126
Stone/slag
wool
Deaths
SMR
95% ci
27
91
60–132
12
124
64–217
11
195
97–348
50
111
82–146
Continuous
filament
glass
Deaths
SMR
95% ci
11
139
69–248
2
104
13–374
2
333
40–1204
15
143
80–236
From: Saracci et al (1984)
6Environmental surveys (Esmen, 1984; Ottery et al, 1984) showed that the
levels of fibre exposure were low, providing very little support for suggestions
that the excess of lung cancer was related specifically to the fibre exposures.
Cherrie et al (1986) reported on their re-assessment of the exposure levels in
conformity with the then new standard for fibre counting (WHO/EURO Technical
Committee, 1985). Although using the new standard approximately doubled the
fibre counts, they were still considered by the authors to be low: generally <0.1
f.ml-1 (fibres per millilitre) for stone/slag wool; <0.05 f.ml-1 for glass wool; and
<0.01 f.ml-1 for continuous filament. In one of the stone/slag wool secondary
process groups, fibre counts reached an average of 0.67 f.ml-1. The very few
workers in the process which produced fine glass fibre ear plugs had exposures
averaging 1.0 f.ml-1. It should be noted that continuous glass filaments rarely have
diameters under about 5 µm. So these are not included as respirable fibres, under
any of the fibre counting rules for assessing exposure levels.
Two other studies of relevance were published at this time. Shannon et al
(1984) reported on a mortality study of glass wool production workers in a
Canadian factory. They also reported raised lung cancer mortality, with seven
deaths, giving an SMR of 166 (95% ci 67–342). From a more detailed analysis,
they did not consider that the lung cancer mortality excess was due to fibre
exposure. Meanwhile results of a study of Swedish construction workers who
used MMVF regularly showed an increased incidence of respiratory cancer.
However, only a small proportion of these cases were considered likely to be due
to exposure to MMVF (Engholm et al, 1984), although the findings did suggest an
association between respiratory cancer risk and MMVF exposure. It was not
possible to determine which types of MMVF were being used by these con-
struction workers. Many of these workers were also exposed to asbestos dust.
So there was a need to temper the observations of some excess of lung cancer
with a recognition that not all the excess was likely to have been caused by
exposure to MMVF. Clearly the epidemiological studies needed to be continued,
to raise the power to detect lung cancer risk, and to permit analyses taking into
account confounding factors.
2.3 Third WHO European Office Symposium on MMVF
The third WHO Conference on “Man-made mineral fibres in the working
environment” was held at WHO, Copenhagen in October 1986. The
epidemiological session included follow-up reports on the European and
American studies, and on the smaller Canadian study of glass fibre production
workers (Simonato et al, 1987, 1988; Enterline et al, 1987; Shannon et al, 1987).
Engholm et al (1987) reported further on their study of respiratory cancer
incidence in Swedish construction workers.
2.3.1 The European Study
In the IARC-coordinated European study, the follow-up was extended for a
further four years. The pattern of lung cancer mortality by years since first
7employment (Table 2) was similar to that shown in Table 1. For glass wool
production workers, the lung cancer mortality was significantly raised overall,
based on standardization to national rates, but the excess disappeared when
standardized using local rates. For stone/slag wool production workers, the SMR
for lung cancer for workers with at least 30 years since first employment (12
deaths) had reduced slightly to 185 with 95 per cent confidence interval (95% ci
95–322), based on local mortality rates, where available. The trend with
increasing time from first employment remained evident. In practice, the use of
local or national rates for standardization had little effect in the stone/slag wool
sector. For continuous filament production, this report shows no deaths for those
first employed at least 20 years previously, compared with four in the earlier study
(Table 1). It must be presumed that these missing cases were all among the office
workers excluded in this study, but included previously.
An important feature of this 1987 report is that the analysis was extended
considerably in scope, in particular by analysing those with less than one-year of
employment separately, by considering the technological development of the
industry, and by assessing the effects of potential confounding exposures.
Those employed for less than one year in the production industry had a
markedly higher SMR for all causes (SMR 142, 95% ci 132–153), based on 741
deaths, compared with an SMR of 102 (98–107) for those employed for one or
more years, based on 1978 deaths. This excess mortality for the short-term
workers existed for all major causes of death, except lung cancer, for which the
SMRs were: short-term workers 113 (79–157); longer-term workers 128
(109–150).
Table 2. European Cohort Study: mortality analysis up to 1981-1983. Stone/slag wool
production: Deaths from cancer of the trachea, bronchus and lung, SMRs, and 95%
confidence intervals (both sexes, expected deaths based on local reference populations).
Years since first employment
Production <20 years 20–29 years 30 + years Total
Early
technological
phase
Deaths
SMR
95% ci
0
0
0–620
4
317
86–812
6
295
108–642
10
257
123–473
Intermediate
technological
phase
Deaths
SMR
95% ci
3
79
16–230
7
164
66–338
4
217
59–556
14
141
77–237
Late
technological
phase
Deaths
SMR
95% ci
44
120
87–161
11
90
45–161
2
77
9–278
57
111
84–144
Total, all
phases
Deaths
SMR
95% ci
47
114
84–152
22
124
77–187
12
185
95–322
81
124
99–154
From: Simonato et al, 1987
The Historical Environmental Investigation (Cherrie & Dodgson, 1986) for the
European MMVF cohort study extended the earlier exposure assessments (Ottery
et al, 1984; Cherrie et al, 1986) to consider the effects of changes in production
8methods over time. They identified three factors believed to be influential in
reducing exposures to MMVF: addition of oil to the process of fibre production;
increase in the nominal fibre size; and introduction of continuous production of
insulation.
Based on the above factors, three technological phases were defined for the
epidemiological analyses. In the early phase, batch production was in use and/or
no oil was added to the fibres during production. In the late phase, production
methods were judged to be similar to modern production techniques. An inter-
mediate phase was identified in some factories. Table 2 shows ten deaths from
lung cancer among those stone/slag wool production workers first employed
during the early technological phase, resulting in a significantly raised SMR of
257 overall, and with high SMRs for those employed for 20 or more years.
However, only 0.7 lung cancer deaths were expected for those with less than 20
years since first employment, so that any trend is possibly more apparent than
real. For those workers first employed in the late production phase, a decreasing
trend of SMR with increasing time since first employment appears, but there are
too few people with a long time since first employment for this trend to be
convincing.
Yet, the patterns of mortality in the margins of Table 2 show trends in lung
cancer mortality by years since first employment and by technological phase.
These univariate trends are consistent with the hypothesis that exposure to
stone/slag wool was a cause of lung cancer. They are also, of course, consistent
with the hypothesis that other factors related to employment in stone/slag wool
production were a cause of lung cancer.
A similar analysis for glass wool production workers shows no evidence of an
association of lung cancer mortality rates and time since first employment or with
technological phase when mortality rates were calculated based on local reference
populations.
In assessing these findings, the exposure levels should be considered. Based on
a mathematical model of the effects of changing production conditions, Dodgson
et al (1987) presented, for each technological phase and factory, upper and lower
estimates for the time-weighted average exposure levels. For the glass wool
plants, the authors concluded that mean airborne glass fibre levels in the early
technological phase “were little different from current levels (about 0.1 [respir-
able] f.ml-1 or less)”.
For the stone/slag wool factories, taking the mid-point between these upper and
lower estimates, the early phase exposures ranged between 0.15 and 1.2 f.ml-1. By
the late technological phase, these exposure levels had dropped to between 0.08
and 0.11 f.ml-1. The differences between the phases accord reasonably with the
results from an experimental simulation of past exposure conditions (Cherrie et al,
1987).
In addition to defining the technological phases, Cherrie and Dodgson (1986)
also assessed other environmental risk factors (asbestos, polycyclic aromatic
hydrocarbons, polychlorinated biphenyls, formaldehyde, and arsenic). These risk
factors, and the use of slag in the stone/slag wool production process, were
9analysed by Simonato et al (1987, 1988). They reported a doubling of lung cancer
mortality in stone/slag wool production when slag was being used, with no
evidence of an excess otherwise. This is described as difficult to interpret as the
periods with no slag wool use coincided with the late technological phase. Copper
slag was used to some extent, showing an additional excess but based on only four
deaths, so the possibility of arsenic-related lung cancers cannot be proven.
For asbestos, there was an apparently anomalous result, with an SMR in
stone/slag wool below 100 when asbestos was in use, and about 170 when no
asbestos was being used in production. However, the use of asbestos was one
criterion for exclusion of a factory from the European cohort study, so no pattern
should have been expected. For none of the other potential confounding exposures
was there any evidence of an association with lung cancer mortality.
A cancer incidence study was also undertaken for the factories in those
countries with adequate cancer registries. The results are very similar to those in
the mortality study.
The only other causes of death to show a significantly elevated mortality rate
was “Accidents, poisoning and violence”, and its subset “Suicide”. In the cancer
incidence study, cancer of the buccal cavity and pharynx showed a just significant
excess – the Standardized Incidence Ratio, based on 26 deaths, was 153 with 95%
ci 99.9–224. The excess occurred in both stone/slag wool and glass wool
production, but the pattern of the cancer incidence with time since first employ-
ment was irregular.
2.3.2 The American cohort study
As for the European cohort study, the University of Pittsburgh study of 16,661
workers in 17 factories extended the follow-up by a further five years. Table 3
presents a global overview of malignant neoplasm mortality rates for all factories
combined. Separate data by type of production were not published, except for
respiratory cancer presented in Table 4, and discussed below. There was a small
excess of malignant neoplasms, which was higher and just statistically significant
for those with more than 20 years since first employment. For buccal cavity
cancer, the SMR was 122, raised equally independent of the number of years since
first employment. This rate is also almost identical to the SMR of 123 (95% ci
65–210) in the European study.
For both respiratory cancer and lung cancer, the SMR was close to 100 for
those with less than 20 years since first employment in MMVF production.
However, for those with more than 20 years since first employment, the SMR was
very close to being statistically significant.
Table 4 presents the mortality rates for respiratory cancer by type of pro-
duction. As for the European study, the main excess respiratory cancer mortality
occurred among the mineral wool (stone/slag wool) production workers, with
a statistically significant excess overall, but no pattern by time since first employ-
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Table 3. American Cohort Study: mortality analysis up to 1982. Deaths from selected
causes, SMRs, and 95% confidence intervals. (Males only. Expected deaths based on
local population.)
Years since first employment
<20 years 20 + years Total
All malignant
neoplasms
Deaths
SMR
95% ci
312
100
89–112
735
108
100–116
1047
105
99–112
Buccal cavity and
pharynx
Deaths
SMR
95% ci
12
122
60–132
23
122
64–217
35
122
82–146
Respiratory
system
Deaths
SMR
95% ci
90
100
80–123
301
112
99.7–125
391
109
98–120
Trachea, bronchus
and lung
Deaths
SMR
95% ci
82
97
77–120
288
113
100–127
370
109
98–121
From: Enterline et al, 1987.
ment. The fibrous glass filament production workers showed no evidence of an
excess respiratory cancer rate, and so the two factories that produced both fila-
ment and glass wool have been included with the glass wool production factories
in Table 4. There is a very slight trend of increasing mortality with time, but the
evidence of an excess is weak, and similar in magnitude to that seen in the
European study.
Table 4. American Cohort Study: mortality analysis up to 1982. Respiratory cancer
deaths, SMRs, and 95% confidence intervals by production process and time since first
employment. (Males only. Expected deaths based on local reference populations.)
Years since first employment
Production <20 years 20–29 years 30 + years Total
Fibrous glass
filament
Deaths
SMR
95% ci
15
66
37–109
36
119
83–165
13
80
43–137
64
92
71–118
Fibrous glass wool
(+ glass filament in
2 factories)
Deaths
SMR
95% ci
60
105
80–135
104
108
88–131
103
114
93–138
267
109
97–123
Fibrous glass – all
Deaths
SMR
95% ci
75
94
74–118
140
111
93–131
116
109
90–131
331
105
94–117
Ever produced
small diameter
fibrous glass
Deaths
SMR
95% ci
8
113
49–222
8
105
45–206
6
198
73–431
22
124
78–187
Mineral wool
Deaths
SMR
95% ci
15
143
80–236
20
126
77–195
25
135
87–199
60
134
102–172
From: Enterline et al, 1987
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In five factories, small diameter fibres were produced, but in lower volumes
than fibrous glass wool. These fibres are typically manufactured in low volumes
for special purposes, such as aircraft insulation, to have diameters under about
1 µm. Workers employed in the manufacture of these small diameter fibres would
also have been involved in fibrous glass production. So the workers in these
factories were sub-divided into ever- and never-employed in small diameter fibre
production. Table 4 shows that overall, the respiratory cancer SMR for the ever-
producers, based on local rates, was 124 (78–187). This compared with 105
(90–121) for the never-producers. Those first employed in small diameter fibre
production at least 30 years earlier had a raised SMR of 198, based on six
respiratory cancer deaths.
The authors also reported that exposure levels to small diameter fibrous glass
were about ten times higher than for exposure to other fibrous glass. They
commented that “Data presented here are consistent with the notion that work in
departments that produced small diameter fibres is associated with respiratory
cancer”.
A major feature of this American cohort mortality study is that fibre exposures
have been estimated for all the production workers. Table 5 shows the mortality
pattern by increasing levels of cumulative fibre exposure, for the same product
groups as used in Table 4 (other than for ever-production of small diameter fibres,
for which the data were not presented). Overall, there is a decrease in SMR with
increasing cumulative fibre exposure, with this trend being very strong for the
mineral wool sector. For fibrous glass wool, there is some reduction in the SMRs,
as cumulative exposure increases, but the values are rather lower than for mineral
wool. For fibrous glass filament, the SMRs are generally low, reflecting the
overall SMR of 92 (Table 4).
To investigate the pattern of mortality further, Enterline et al (1987) nested a
case-referent study within their cohort study, using respiratory cancer cases 1950-
1982 as the cases, and a four per cent stratified random sample of non-cases as the
referents, subject to exclusion criteria related to age, the specific dates, and
mortality from respiratory cancer or non-malignant respiratory disease (other than
influenza or pneumonia). Smoking information was sought from any of the
controls still alive, and from knowledgeable informants. For fibrous glass,
attempts to get smoking histories were successful for 242 of 330 respiratory
cancer cases and for 387 of 529 referents. For mineral wool, the success rates
were 45 of 60 cases and 49 of 67 referents.
For both fibrous glass wool and mineral wool, an analysis including a smoking
index, never- or ever-smoker, showed a very highly significant relation of
respiratory cancer to smoking, and no significant association with cumulative
fibre exposure. However, for mineral wool, the association with cumulative fibre
exposure was positive, and this was considered unexpected given the pattern of
decreasing SMRs with cumulative fibre exposure alone (Table 5).
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Table 5. American Cohort Study: mortality analysis up to 1982. Respiratory cancer
deaths, SMRs, and 95% confidence intervals by production process and cumulative fibre
exposure. (Males only. Expected deaths based on local reference populations.)
Cumulative fibre exposure1
Production Lowest Lower Higher Highest
Fibrous glass
filament
Deaths
SMR
95% ci
53
96
73–127
3
51
11–160
7
109
44–255
1
62
2–348
Fibrous glass wool
(+ glass filament in
2 factories)
Deaths
SMR
95% ci
147
120
102–141
40
109
74–148
37
81
57–112
43
108
78–146
Fibrous glass – all
Deaths
SMR
95% ci
200
113
97–129
43
101
73–136
44
84
61–113
44
106
77–143
Ever produced
small diameter
fibrous glass
Deaths
SMR
95% ci
7
185
74–382
22
164
103–248
18
119
70–118
13
104
55–177
Note: The cumulative fibre exposure groups are as follows (in f.ml-1.months)
Fibrous glass: <2.14 2.14–4.67 4.67–9.99 10 +
Mineral wool: <4.67 4.67–21.88 21.88–99.99 100 +
From: Enterline et al, 1987
In further analyses, smoking was included in the analysis as duration of smoking
and years since first smoking. For fibrous glass, the smoking history was complete
enough for 211 cases and 374 referents. In these analyses, there remained no
significant association of lung cancer risk with cumulative fibre exposure, but
there was the expected pattern with duration of smoking.
For mineral wool, adequate smoking histories were available for 38 cases and
43 referents. The logistic regression analyses showed a significant association of
increasing respiratory cancer risk with increasing cumulative exposure to fibres,
as well as the expected association with cigarette smoking. The log odds ratio for
time-weighted cumulative exposure (f.ml-1.months) was 0.008 (P=0.009).
In contrast to this positive association, Table 5 shows for mineral wool a
marked decline in respiratory cancer SMR with increasing estimated cumulative
fibre exposure. Trying to reconcile these contrasting results, the authors analysed
the data by year of hire, reporting higher respiratory cancer rates for those hired
most recently, suggesting that this was concordant with the patterns of increasing
smoking rates over time. The main conclusion of this reconciliation was that there
was a marked confounding of the mortality patterns by smoking.
2.3.3 Other mortality studies
At this third symposium on MMVF, Shannon et al (1987) presented an update on
the Ontario glass fibre workers study, as did Engholm et al (1987) on the Swedish
respiratory cancer incidence study of construction workers.
The Ontario study of one glass fibre production factory covered 2,557 men,
who had worked in the factory for at least three months. The only statistically
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significant excess mortality rate was for lung cancer. The SMR for those who
worked in fibre production was double expectation: 19 men; SMR 199; 95% ci
120–311. However, the authors point out that several of these lung cancer cases
had been employed for a short period only, or had short latency. They also
considered that the lung cancer mortality pattern in relation to either duration of
employment or years since first employment was “not consistent with an
occupational cause”.
The Swedish study of the incidence of respiratory cancer among 135,000
construction workers was extended to the end of 1983. About ten years earlier all
the workers had been interviewed, and inter alia questioned about whether they
had ever worked with glass wool, mineral wool, or with materials containing
asbestos. They were asked when they first did such work and for how long.
Industrial hygienists graded each of the 160 tasks in the industry on a six-point
scale of potential for exposure to MMVF (without differentiation by type of fibre)
and asbestos. Tobacco smoking information was also collected.
Overall, there was an excess mortality from industrial accidents. For all causes,
the SMR was 68, based on 7,356 deaths. For malignant neoplasms of the trachea,
bronchus and lung, the SMR was also low, being 86 (95% ci 79–95), based on
444 deaths. Non-malignant respiratory disease mortality was even lower, with an
SMR of 46 (40–53). The cancer incidence analysis found an excess of pleural
mesothelioma, with 23 cases compared with eleven expected.
In the nested case-control study, each of the 424 incident lung cancer cases was
matched to five control subjects alive for at least as long as the case since the date
of original interview. The authors note that there was a poor relation between the
hygienists’ assessments of asbestos exposure, and self-reported exposure. Also,
the analysis was limited by the very high correlation between the assessments of
exposure to MMVF and asbestos. The final analyses showed a lung cancer
relative risk for MMVF exposure, adjusted for asbestos exposure, smoking and
population density of 1.21 (95% ci 0.60–2.47). For asbestos exposure, the
adjusted relative risk was 2.53 (0.77–8.32). The conclusion was that “it would
appear that there is a risk related to asbestos exposure but no evidence of a risk
related to [MMVF] exposure after allowing for asbestos” but that because of the
high correlation between the two exposures “the follow-up of this cohort so far
provides insufficient data for an evaluation of risks associated with inhalation of
[MMVF] fibres.”
Moulin et al (1986) reported on a study of cancer incidence among some 1,400
stone wool producers in northern France over ten years. They found no excess of
lung cancer, but they did find a statistically significant doubling of incident
cancers of the upper respiratory and alimentary tract. However, the cancer
registries used as the basis for the cancer incidence rates were not located in the
area of the factory, and subsequently a follow-up study (Czernichow et al, 1989)
did not confirm the original findings.
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3. The IARC and IPCS reviews of the health effects
of MMVF, 1987
Just before this third WHO Symposium discussed above, a supplement to the
Scandinavian Journal of Work, Environment and Health was published, devoted
to the European Study co-ordinated by IARC. The mortality study report
(Simonato et al, 1986) was effectively identical to that presented in Copenhagen,
and separate reports were made for the production factories in each of the seven
countries of the study. This supplement was introduced by a review of the
epidemiological evidence, and it is relevant to note that Saracci (1986) closes the
review:
“The 1982 follow-up was undertaken with the awareness that more
observation may not necessarily bring about more clarity. However, after
the exercise was completed, it appeared that the extended follow-up
combined with the historical industrial enquiry could lead some steps further
towards clarity – in my opinion, in two different directions. First, it endorses
the indication from the previous follow-up (1977) that no adverse long-term
health effects have been detectable in terms of mortality throughout almost
all segments of the MMMF producing industry. This outcome is of
paramount importance for the employees and management in this industry,
notably if it receives reconfirmation in the future from longer observations
of the workers exposed for longer periods. Second, it supports the inference
that MMMF – as present in the environmental conditions of the early slag
wool/rock wool production – may have played a role in the causation of
lung cancer.”
Thus, the scene was painted for the formal reviews of hazard, by IARC (1988),
and of environmental risk, by the International Programme on Chemical Safety
(IPCS, 1988).
3.1 IARC Evaluation of Carcinogenic Hazard, 1987
IARC convened a Working Group of 23 independent scientists in June 1987 to
consider the hazard classification for the carcinogenicity of MMVF and of Radon
(IARC, 1988) (Table 6). The report assessed the levels of MMVF exposure as
published to that date, and noted that exposure levels in glasswool production
have generally been 0.1 respirable f.ml-1 or less, and about 0.2–0.3 f.ml-1 in stone/
slagwool production. Airborne fibre concentrations in the production of fine glass
fibres were some tenfold higher than in glasswool production, averaging 0.8
f.ml-1. In ceramic fibre production factories, the average airborne fibre con-
centrations were yet a little higher, up to 3 f.ml-1.
These exposure levels need to be viewed from the perspective of asbestos
exposure levels at about the same time. In production, exposure levels ranged up
to 200 f.ml-1 in insulation production, up to 140 f.ml-1 in asbestos textile
production and around 20 f.ml-1 in the production of other materials (IARC,
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1977). These levels are some 100 times higher than the maximal exposures
reported for those doing similar work during MMVF production and use.
Table 6. IARC (1988) Classification for the carcinogenicity of MMVF.
Man-Made Vitreous Fibres
Evaluation
Glass Wool & Fine
Glass Fibres Glass Filaments
Rock (Stone) and Slag
Wool Ceramic Fibres
Human carcinogenicity
“There is inadequate
evidence for carcino-
genicity to humans”
“There is inadequate
evidence for carcino-
genicity to humans”
“There is limited evidence
for carcinogenicity to
humans”
“There are no data
available on the
carcinogenicity to
humans”
Animal carcinogenicity
“There is sufficient
evidence for the
carcinogenicity of glass
wool in experimental
animals”
“There is inadequate
evidence for the
carcinogenicity of glass
filaments in experimental
animals”
“There is limited evidence
for the carcinogenicity of
rock (stone) wool in
experimental animals”
“There is sufficient
evidence for the
carcinogenicity of
ceramic fibres in
experimental
animals”
Overall Evaluation
2B 3 2B 2B
Possibly carcinogenic to
humans
Not classifiable as to their
carcinogenicity to humans
Possibly carcinogenic to
humans
Possibly
carcinogenic to
humans
Extracted from: International Agency for Research on Cancer. IARC monographs on the
evaluation of the carcinogenic risks of humans. Man-made vitreous fibres and radon, vol 43. 1988.
On the mortality and cancer incidence studies, the conclusions of the IARC
Working Group were similar to those presented above, and particularly as ex-
pressed in the quotation from Saracci. Table 6 shows the classification of MMVF,
as used by IARC (1988). The concern expressed that stone/slag wool may be
carcinogenic, but without convincing evidence of an association with fibre expo-
sure, is reflected in the classification of “limited evidence” of carcinogenicity to
man.
Table 6 also shows the conclusions drawn by the IARC Working Group from
the experimental studies, and the overall evaluation. All the fibre groups, except
glass filaments, were considered to be “possibly carcinogenic to humans (Group
2B)”.
3.2 IPCS Review of Environmental Risk, 1987
Three months after the IARC Working Group meeting, IPCS (1988) convened its
own review by 19 independent scientists of environmental risk to humans through
exposure to MMVF. The evidence considered was inevitably the same as in the
IARC report; six of the scientists were also members of the IARC working group.
However, there was one key difference between the two reports: the grouping
of fibre types differed, as may be seen in Table 7. In particular, special purpose
glass fibres were separated from glass wool, on the basis of method of
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manufacture, size and use. This is reflected in the higher fibre exposure levels for
the finer fibres (Esmen et al, 1979). It is the IPCS grouping which has generally
been followed in subsequent scientific reports and regulatory decisions.
Table 7. IPCS (1988) Classification of MMVF.
Man-Made Vitreous Fibres
Continuous Filament Insulation Wool Refractory Fibres Special PurposeFibres
1) Glass
1) Glass wool
2) Stone wool
3) Slag wool
1) Ceramic
2) Others 1) Glass microfibres
Overall Environmental Assessment
The overall picture indicates that the possible risk for the general population is very low, if
there is any at all, and should not be a cause for concern if current low exposures continue
The IPCS reviews are more concerned with risk, rather than hazard, and with a
wider range of possible adverse health effects. For the occupationally exposed, the
review considered dermatitis, eye irritation and non-malignant respiratory disease.
For the first two of these, the data were considered insufficient to derive any
exposure-response relation; for non-malignant respiratory disease, conclusions
could not be drawn concerning the nature or extent of any association.
As for the IARC review, IPCS considered that for production workers, the lung
cancer epidemiology was “consistent with the hypothesis that it is the airborne
fibre concentrations that are the most important determinants of lung cancer risk”.
IPCS also noted that higher exposure levels could have occurred in the production
of ceramic fibres and small diameter special purpose glass fibres, and in the
application and spraying of insulation wool in confined spaces.
For the general population, IPCS noted that exposure levels were several orders
of magnitude lower than exposures associated with lung cancer risks. The review
concluded
“Thus, the overall picture indicates that the possible risk for the general
population is very low, if there is any at all, and should not be a cause for
concern if current low exposures continue.”
4. The Years from 1987 to 2002
At the start of this second half of these 25 years, there was public and regulatory
concern about the possible health effects of exposure to MMVF. For example, the
UK Health and Safety Executive (1986) published a Guidance Note on exposure
to MMVF, which has been updated periodically. Also the UK Committee on
Carcinogenicity (Health and Safety Executive, 1987) reviewed the evidence about
workplace exposure, on the human evidence of lung cancer risk, and from
experimental studies. Its statement advised that
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“it would be prudent to act on the basis that sufficient exposure to any form
of MMMF in the production industry (or in the user industries) may increase
the risk of lung cancer among the work force”.
These concerns prompted a Resolution of the International Labour Office (ILO) in
1986 concerning health risks of occupational exposure to fibres. This formal
resolution required ILO to convene a meeting of “Experts on Safety in the Use of
Mineral and Synthetic Fibres”, which was held in Geneva in April 1989 (ILO,
1989). The primary outcome was that a Code of Practice for Safety in the Use of
Mineral and Synthetic Fibres should be prepared.
Among the Unions, the US AFL-CIO (1991) recommended to the US
Environmental Protection Agency that there should be a permissible exposure
limit of 1 f.ml-1 for respirable glass fibres, time-weighted average. The Inter-
national Federation of Building and Wood Workers (1993) also recommended a
draft policy on MMVF and a list of control measures. They demanded that
MMVF dust should be declared a carcinogenic substance, and supported the ILO
proposal for a Code of Practice.
The epidemiological research continued. The next sections consider the cohort
mortality and cancer incidence studies; the case-control studies; and additional
evidence from other epidemiology.
Miettinen and Rossiter (1990) argued at this time that the conclusions from the
cohort study results were biassed inter alia by assuming that the national or
regional comparison populations were actually comparable to the cohort
populations, in particular in relation to smoking habits. Later in this review, we
shall see that epidemiological approaches not dependent on SMR analyses may
lead to a different conclusion about potential lung cancer risk.
4.1 Cohort mortality and cancer incidence studies
4.1.1 The European cohort study: Lung cancer mortality
Boffetta et al (1995, 1997) and Sali et al (1999) have reported on the update of the
major European study, with a mortality update to 1990 and cancer incidence to
1994-1995. The findings and conclusions were essentially unchanged from the
previous follow-up.
Although the number of person-years of follow-up increased by 34 per cent to
nearly 500,000, there was little change in conclusion from the previous study
(Simonato et al, 1987, 1988). For glass wool production workers, the lung cancer
mortality remained significantly raised overall, based on standardization to
national rates, but the excess reduced to an SMR of 112 (95% ci 95–131) when
standardized using local rates. For stone/slag wool production workers, the
number of lung cancer deaths for workers with at least 30 years since first
employment increased from 12 to 42 deaths, but the SMR reduced slightly to 171
(95% ci 123–230), based on local mortality rates, where available. In practice, the
use of local or national rates for standardization had little effect in the stone/slag
wool sector. For continuous filament production, this report now shows six lung
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cancer deaths for those first employed at least 20 years previously; this SMR is 93
(95% ci 34–203).
For the stone/slag wool sector in more detail, the trend with increasing time
from first employment and technological phase remained evident (Table 8).
However, comparison of this table with Table 2 for the previous follow-up period,
shows that the trends are less marked. A more detailed analysis by period of
follow-up led the authors to suggest that “the excess [lung cancer] risk may be
concentrated among workers starting their employment in the industry more than
40 years ago”, as more recent recruits have a lower SMR for lung cancer.
This extended follow-up again considered the possible confounding effects of
exposure to other potential carcinogens in the working environment of the stone/
slag wool production factories: asbestos, slag, bitumen, and formaldehyde. There
were slightly higher SMRs related to asbestos, slag and formaldehyde exposures,
but not for bitumen. These differences were small and not enough to account for
the excess lung cancer mortality overall. However, the authors did record that
there was additional evidence available indicating that all workers in the German
factory could have been exposed to asbestos.
The importance of slag in this environment is that the metal slags that were
used were from the production of lead and copper. These could lead to airborne
exposures to arsenic, lead and cadmium.
To investigate further the relation of lung cancer risks to stone/slag wool
exposure, Consonni et al (1998) undertook a multivariate Poisson regression
analysis, using exposure estimates lagged by 15 years. These estimates of cumula-
tive and maximal annual exposure to airborne respirable fibres were calculated for
each worker, based on a mathematical model of exposure levels in each factory
over time (Krantz et al, 1991). This model did not permit differential assessment
of exposure by job or task.
Table 8. European Cohort Study: mortality analysis up to 1990. Stone/slag wool
production: Deaths from Cancer of the trachea, bronchus and lung, SMRs, and 95%
confidence intervals (both sexes, expected deaths based on local reference populations).
Years since first employment
Production <20 years 20–29 years 30 + years Total
Early technological
phase
Deaths
SMR
95% ci
0
0
0–605
4
317
87–813
7
175
70–361
11
187
93–335
Intermediate
technological phase
Deaths
SMR
95% ci
3
78
16–228
8
152
66–299
9
149
68–282
20
132
81–204
Late technological
phase
Deaths
SMR
95% ci
62
127
97–162
43
134
97–180
26
178
116–261
131
137
115–163
Total, all phases
Deaths
SMR
95% ci
65
122
94–155
55
142
107–185
42
171
123–230
162
139
118–162
From: Boffetta et al, 1995, 1997
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Table 9. European Cohort Study: mortality analysis up to 1990. Stone/slag wool
production: Relative risks of death from cancer of the trachea, bronchus and lung, by
exposure to respirable fibres (males only).
Cumulative exposure to respirable fibres (f.ml-1.years)
Exposure groups 0–0.007 0.008–0.136 0.137–1.367 1.368 +
All workers
Deaths
RR
95% ci
39
1
reference value
40
1.3
0.8–2.4
40
1.2
0.7–2.1
40
1.5
0.7–3.0
Exposure groups 0–0.139 0.140–0.729 0.730–2.622 2.623 +
Workers
employed > 1
year
Deaths
RR
95% ci
25
1
reference value
24
0.9
0.4–2.0
24
0.8
0.3–1.9
24
1.0
0.4–2.7
From: Consonni et al, 1998.
Table 9 shows the relative risks for four groups of estimated exposure to airborne
stone/slag wool respirable fibres. These relative risks were standardized for
country (Denmark, Sweden, Norway, Germany), age, calendar year, time since
first employment and employment status.
For all male workers, there were 159 lung cancer deaths, and the exposure
level ranges had been chosen to give equal numbers of deaths in each group.
There was a slightly increasing trend (P=0.04) of relative risk with increasing
estimated exposure to airborne respirable fibres (Figure 1). For maximal annual
fibre exposure, there was no trend.
Figure 1. Cumulative exposure to MMVF and realtive Risk of Lung Cancer (from
Consonni et al, 1998).
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For the workers employed for at least one year, there was no trend at all with each
relative risk equal to or less than unity (Figure 1). For maximal annual exposure,
there was a tendency for the relative risk to decrease with increasing exposure
level.
It is perhaps surprising that the authors concluded “We found a positive
association ...”, but they do continue
“However, the lack of statistical significance, the dependence of the results
on inclusion of short-term workers, the lack of consistency between
countries, and the possible correlation between exposure to respirable fibers
and to other agents reduce the weight of such evidence.”
4.1.2 The European cohort study: Other causes of death
There were five mesothelioma cases; one in the glass wool sector, who had
worked in one production factory for 25 years, but who had a considerable lung
burden of asbestos fibres, believed not to be associated with employment in fibre
glass production. Of the four in the stone/slag wool sector, two cases had worked
for less than one year and had been employed there late in life. The other two had
been employed in the German factory, and one of these had received compen-
sation for asbestos-related disease. It seems unlikely that there is an association
between MMVF exposure and mesothelioma, based on the evidence in this study.
The SMRs were raised, but not significantly, for cancers of the oral cavity,
pharynx and larynx, for the pancreas, rectum, bones, and bladder. In each case
there was little evidence to suggest any association with exposure to MMVFs.
However there was a significant excess of neoplasms coded as “ill-defined and
unspecified sites” which occurred in all three sectors of the production industry.
Sali et al (1999) reported separately on non-neoplastic mortality. They con-
cluded that non-neoplastic mortality appears unrelated to employment in the
European MMVF production industry. However, they did recommend further
investigations on mortality from ischemic heart disease and non-malignant renal
disease. The basis for the first recommendation was that there was an increase in
ischemic heart disease for those with at least 30 years since first employment in
the stone/slag wool and continuous glass filament sectors. However, most of this
excess occurred for those employed for less than one year in MMVF production.
For renal diseases, the authors report a suggestive trend of increasing risk with
duration of employment in the stone/slag wool sector and by technological phase.
However, these observations are based on only six deaths in total in this sector of
the production industry.
For cirrhosis of the liver, there was increased mortality among the stone/slag
wool, primarily among the short-term workers. However for glass filament
workers, those with more than one year of employment had a significantly raised
SMR of 235 (95% ci 128–394) and there was a suggestion of an increasing trend
with increasing duration of employment.
The above findings suggest that there may be lifestyle factors affecting non-
neoplastic mortality rates, supported by the observations in the stone/slag wool
21
sector of high mortality rates for mental diseases. For short-term workers, the
SMR was 467 (95% ci 313–671), but for the longer term workers, the SMR was
also high (SMR 186, 95% ci 115–284). Death rates for accidents, poisoning and
violence were also markedly raised, particularly but not only among the short-
term workers.
4.1.3 The European cohort study: Cancer incidence
The cancer incidence study was extended to 1994 or 1995, dependent on country,
for Denmark, Sweden, Norway and Germany (Boffetta et al, 1999). Those em-
ployed for less than one year were excluded. For lung cancer incidence, the results
were similar to the mortality findings, as expected, but with fewer cases.
For both the stone/slag wool and glass wool sectors, lung cancer incidence
increased with increasing years since first employment, with significance levels of
0.1 and 0.2 for trend, but with no individual relative risks significantly higher than
1. There was a slightly increasing trend in relative risk by duration of employment
for stone/slag wool production workers, and a slightly decreasing trend for those
on glass wool production. The results by technological phase show the greatest
discrepancy relative to the SMR results, as for both sectors the relative risks for
the early technological phase were less than 1, relative to the late technological
phase.
4.1.4 The American cohort study: stone/slag wool sector
The follow-up of the University of Pittsburgh American cohort study was
extended until 1989 for the stone/slag wool production sector, and up to 1992 for
the glass wool and continuous filament sectors (Marsh et al, 1996; 2001).
An important aspect of these follow-up studies was that individual estimates
were made of exposure to total airborne fibres, respirable fibres, formaldehyde
and silica (Smith et al, 1994). In addition, for the stone/slag wool sector, qualita-
tive estimates of the potential for exposure were also made for asbestos, arsenic,
asphalt, PAHs, phenolics, radiation, and urea. The choice of potential exposures
assessed was dependent on the history of the factory.
One stone/slag wool factory (number 17) had closed, and declined to partici-
pate further, and the analyses were consequentially limited. For this factory, lung
fibre burden analyses found that four of six lung cancer cases had raised levels of
amosite fibres in the lung, whereas no such excess was found for any other worker
in this cohort study (McDonald et al, 1990). Historical evidence confirms that
asbestos had been used for many years in this factory, at least as far back as the
early 1930s (Merewether, 1932) shortly after the factory had opened in 1929.
This factory 17 has been designated by Marsh et al (1996) as the O-cohort. The
other five stone/slag wool factories form the N-cohort.
The lower part of Table 10 shows the SMRs for respiratory cancer for the N-
and O-cohorts. For the N-cohort, there were 71 respiratory cancer deaths, for
whom 68 had known employment histories, and so are included in Table 10.
There was no trend in SMR with increasing years since first employment. This
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contrasts strongly with the results for the O-cohort, for which there was an
increasing trend, with significantly raised SMRs overall and for the sub-group
with more than 30 years since first employment.
Table 10. American Cohort Study: mortality analysis up to 1989 or 1992. Respiratory
cancer deaths, SMRs, and 95% confidence intervals by time since first employment
(expected deaths based on local reference populations).
Years since first employment
Production <20 years 20–29 years 30 + years Total
Fibrous glass – all
Deaths
SMR
95% ci
132
92
77–110
219
99
87–114
523
114
105–125
874
106
99.5–114
Fibrous glass >5
years employed
Deaths
SMR
95% ci
63
74
57–95
124
96
80–115
309
115
102–128
496
103
94–112
Mineral wool
N-cohort
Deaths
SMR
95% ci
15
106
60–175
23
135
86–203
30
106
72–151
68
114
89–145
Mineral wool
O-cohort
Deaths
SMR
95% ci
3
95
20–278
8
141
61–278
21
171
106–261
32
152
104–214
From: Marsh et al, 2001, 1996. (Fibrous glass: all workers; Mineral wool: males only.)
The difference between the two cohorts also is apparent for mortality from non-
malignant respiratory disease (excluding influenza and pneumonia). For the main
N-cohort, there were 39 such deaths (five per cent of all deaths) yielding an SMR
of 127 (95% ci 90–174). Table 11 includes the 36 cases with known employment
histories. In the O-cohort, there were 20 deaths (almost ten per cent of all deaths)
and the SMR of 183 was statistically significantly raised (95% ci 112–283). For
one of these 20 deaths, asbestosis was listed as cause of death.
There was one mesothelioma case reported, for a worker in factory 17, the O-
cohort. This is consistent with the evidence of asbestos exposure in this factory.
The only other cause of death worth discussion is nephritis and nephrosis. In
both cohorts, the SMR was above 200 and significantly higher than expected. The
excess appeared unrelated to duration of employment. These results provide
support for the recommendation by the IARC authors that renal diseases
warranted further investigation.
As for the European study, logistic regression modelling of mortality rates was
performed. However, in this study there were individual measures of exposure, as
described above. For the males in the N-cohort, all of whom were employed for at
least one year, the relative risks for respiratory system cancer were 1, 0.72, 0.94
and 0.83 with increasing estimates of cumulative exposure to respirable fibres2.
This was based on all 68 respiratory system cancer cases with known employment
history. After adjustment for all the potential co-exposures and for differences
                                    
2 Not enough details were provided to be able to calculate confidence intervals for the
risk ratios.
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between factories, the ratios became 1, 0.79, 1.01, and 0.93. This pattern is
concordant with the results for those employed for more than one year in the
European study (Table 9 and Figure 1). There is no evidence of any association of
respiratory system cancer mortality and exposure to respirable fibres.
Table 11. American Cohort Study: mortality analysis up to 1989 or 1992. Non-malignant
Respiratory Disease (excluding influenza and pneumonia): Deaths, SMRs, and 95%
confidence intervals by time since first employment (expected deaths based on local
reference populations).
Years since first employment
Production <20 years 20–29 years 30 + years Total
Fibrous glass – all
Deaths
SMR
95% ci
42
76
55–103
117
102
82–113
281
92
82–103
440
92
84–102
Fibrous glass >5
years employed
Deaths
SMR
95% ci
21
64
39–97
68
95
76–125
163
88
75–102
252
88
77–99
Years since first employment
Short term (<5 years) Longer term (≥5 years)
Mineral wool
N-cohort
Deaths
SMR
95% ci
13
131
70–224
23
116
74–174
36
121
85–168
Mineral wool
O-cohort
Deaths
SMR
95% ci
6
155
57–337
14
199
109–334
20
183
112–283
From: Marsh et al, 2001, 1996. (Fibrous glass: all workers; Mineral wool: males only.)
4.1.5 The American cohort study: fibrous glass sectors: Respiratory cancer
All the original fibrous glass factories continued their participation (Marsh et al,
2001), although one factory had closed in 1984. As well as quantitative estimates
of exposure to total and respirable fibres, formaldehyde and silica, qualitative
estimates of the potential for exposure were also made for asbestos, arsenic,
asphalt, epoxy, PAHs, phenolics, styrene and urea. The choice of potential expo-
sures assessed was dependent on the history of the factory, as in the stone/slag
wool sector.
The upper part of Table 10 shows the pattern of respiratory cancer by years
since first employment for all workers, and for those employed at least five years
in fibrous glass production. The present report does not provide detailed cross-
tabulations of respiratory cancer mortality rates by production sector (fine fibrous
glass, continuous filament, fibrous glass wool) and years since first employment.
Detailed comparisons cannot be made with the data in Table 4, for the previous
follow-up to 1982 (Enterline et al, 1987).
For all fibrous glass workers in the present follow-up, there is a pattern of
increasing SMR with increasing time since first employment, and for those first
employed at least 30 years earlier the SMR was raised significantly (P<0.05). For
those employed at least five years, the overall SMR was 103 (95% ci 94–112).
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The pattern of mortality by time since first employment was similar, except that
the SMRs tended to be lower, in line with the general finding that shorter-term
workers have the higher mortality rates. There is no such clear increasing trend of
mortality rates with years since first employment, for all male fibrous glass
workers followed to 1982 (Table 4).
In other univariate analyses of respiratory cancer mortality, Marsh et al found
significantly raised SMRs for short-term workers, white males, the group of
factories which produced both fibrous glass wool and glass filament, mortality
during 1990-1992, those aged 30-39 when hired and those hired in 1950-1959.
However, it is difficult to interpret these individual unstandardized observations.
4.1.6 The American cohort study: fibrous glass sectors: Other causes of death
There was a statistically significant deficit of all malignant neoplasms. In parti-
cular, neoplasms of the digestive organs and peritoneum, breast and prostate were
all significantly low, and none was significantly raised.
There were no cases of mesothelioma among these fibrous glass production
workers.
The non-malignant respiratory disease (excluding influenza and pneumonia)
SMR was raised (SMR 110, 95% ci 101–121) based on the national mortality
rates for the whole period of the study from 1946 (466 deaths). However when
compared with local county rates for the period of their availability (1960-1992),
the SMR was 92; 95% ci 84–102, based on 440 deaths (Table 11). There was no
relation with years since first employment.
Most other non-malignant causes of death showed a statistically significant
mortality deficit for either comparison period. The SMR for nephritis and nephro-
sis was 109 (95% ci 86–135) for the whole period (83 deaths), and 104 (95% ci
81–132) when compared with local rates (70 deaths).
4.1.7 Other cohort studies
The only other cohort studies of production workers during this period (1987-
2000) were of glass filament producers. Shannon et al (1990) reported on a
Canadian study of glass filament production workers. There were 96 deaths traced
among the 1,465 workers who had worked for at least one year. There was a
significant deficit in mortality overall (SMR 76). The lung cancer SMR was
slightly raised (SMR 136; eleven deaths; 95% ci 68–243). However the authors
concluded “Analysis by both duration of employment and cumulative exposure
showed this increase to be inconsistent with an occupational aetiology”.
Chiazze et al (1999) and Watkins et al (1997) studied a glass filament
production plant, using methods described in more detail in section 4.2.4 below.
In particular Watkins et al (1997) investigated a cohort which included 1,074
white women, 130 black women, and 494 black men who worked for a minimum
of one year from the opening of the plant in 1951. Follow-up was until the end of
1991. White women had no significant excess mortality, except for motor vehicle
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accidents. For black men, there was a significant deficit of heart disease. Lung
cancer SMRs were below unity for both white women and black men.
Gustavsson et al (1992) studied a cohort of nearly 3,000 people in Sweden
prefabricating wooden housing. More than 1,000 workers had been exposed to
MMVF used for insulation. This group was selected as the authors considered that
this exposure would not have been confounded by other exposures, unlike in
MMVF production. Both mortality and cancer incidence were analysed.
The lung cancer incidence rate was low, with eleven cases observed and 23.3
expected (SIR 47, 95% ci 24–85). Lung cancer mortality was similarly low, and
showed a trend of decreasing SMR with increasing years of employment: <10
years, SMR 92; 10-19 years: SMR 65; 20+ years, SMR 55.
Ischaemic heart disease rates were also significantly reduced. For the same
three durations of employment, the SMRs were 78, 82 and 81.
Exposure levels for the workers exposed to MMVF were estimated to be up to
0.25 f.ml-1. The authors concluded that “the exposure levels that have prevailed do
not seem to be associated with an increased lung cancer rate”.
4.2 Case-control studies
The cohort study analyses discussed in section 4.1 had increased the number of
person-years at risk considerably, but had done little to clarify the evidence of
risk. There remained raised mortality rates for lung cancer, but the authors could
not conclude that the relation to fibre exposure was causal. Boffetta et al (1995) in
Europe considered that “a carcinogenic effect of exposures occurring in the
[stone/slag wool sector] working environment is a credible explanation”, and that
cigarette smoking, social class effects and co-exposures were unlikely to explain
all the excess lung cancer mortality.
In the USA, Marsh (1991) took the opposite view. In a Research Memoran-
dum, he explained that he did not consider the statistically significant 12 per cent
excess of respiratory cancer deaths (Marsh et al, 1990) carried much weight for
several reasons: marginal statistical significance; and lack of control for
confounders such as cigarette smoking, lifestyle characteristics, racial compo-
sition, and occupational or non-occupational exposures to agents other than fibres.
In the other studies, Shannon et al (1990) did not consider that the lung cancer
excess in their study of glass filament producers had an occupational aetiology.
The wooden house fabricators had a significant deficit of lung cancer incidence
(Gustavsson et al, 1992).
Public and regulatory concern still existed. In Europe for much of the 1990s
decade, the European Commission Committee on the Classification of Dangerous
Substances debated the classification of MMVFs, only reaching a decision in late
1997 (European Commission, 1997). Even this decision was a cause of
controversy, as the German Government disagreed strongly and introduced more
stringent control regulations.
Regulatory discussions were also actively taking place in USA, Australia, New
Zealand and several other countries.
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These concerns and discussions were a strong encouragement for continuing
the research on MMVF production workers, using nested case-control studies
within the two large cohort studies (Boffetta et al, 2000; Marsh et al, 2001) to
provide clear conclusions, if such could exist. These case-control studies followed
several earlier ones among production workers, which will be discussed first.
4.2.1 Case-control study: English glass fibre factory
Gardner et al (1988) conducted a case-control study in an English glass fibre
production factory, comparing 73 lung cancer cases with 506 controls, matched by
sex and date of birth. They found a slightly raised relative risk of 1.2 (95% ci
0.7–2.0). By type of product, the RR for superfine glass fibres was 1.3, for
continuous filament 1.2, and for glass wool 1.1. Some individual relative risks
were significantly raised, but always based on very small numbers of cases.
A major limitation of this study is that no records of smoking habits were
available, and so confounding by tobacco smoking is possible.
4.2.2 Case-control studies: US stone/slag wool producers
Wong et al (1991) identified a cohort of 4841 men who had worked for at least
one year at nine stone/slag wool production factories in the USA. Four of these
factories were also included in the N-cohort of the University of Pittsburgh studies
(Marsh et al, 1996). There were 504 deaths between 1970 and 1989, 61 of which
were ascribed to lung cancer. Individually matched controls (usually two per lung
cancer case) were selected from the other deaths. As no surviving families could
be traced for three cases, nor for the controls for a further three cases, the final
analyses included 55 lung cancer deaths, with 98 controls.
Estimates of exposure to airborne respirable stone/slag wool fibres were made
for each case and control individually, using employment records and industrial
hygiene surveys. Information was collected on tobacco smoking from telephone
interviews with the families, and from personnel data.
This case-control analysis assessed relative risks for tobacco smoking and
exposure to airborne respirable fibres. All the lung cancer cases were tobacco
smokers and they had smoked on average 50 per cent more than the controls.
There was a 33-fold lung cancer mortality relative risk for heavy tobacco smokers,
relative to non-smokers. There was no association of lung cancer risk with
cumulative fibre exposure (f.ml-1.months), when adjusted for smoking habits.
Workers exposed to stone/slag wool fibres were found to have a lung cancer risk
effectively the same as non-exposed workers, with a relative risk (RR) of 0.94.
Marsh et al (1996) nested a case-control study within their follow-up study of
stone/slag wool producers (see section 5.1.4 above). This was largely limited to
the N-cohort, because of the lack of continued participation of factory 17 (the O-
cohort), for which exposure data and employment histories were thus incomplete.
This case-control analysis was restricted to mortality for the limited period
1970-1989, because of expected problems in contacting families of people who
had died more than 25 years ago, and because of doubts about their recall of
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smoking habits. In this 1970-1989 period, there were 54 respiratory system cancer
deaths, and all except one person were smokers. These cases were individually
matched with two controls, born within two years of the case.
Adjusted for smoking, the relative risks for respiratory system cancer with
increasing cumulative respirable fibre groups showed a decreasing trend: 1, 0.64,
0.55, 0.58. Similar trends were present when the analysis was unadjusted for
tobacco smoking, or when the analysis was limited to smokers only. In each case,
those with less than 3 f.ml-1.months of exposure to airborne respirable fibres had
the highest risk, typically 60-70 per cent higher than the more heavily exposed
workers.
Considering only smoking cases, and excluding three cases with all non-
smoking controls, the analysis was extended to assess the effects of the other
occupational exposures (formaldehyde, silica, asbestos, arsenic, asphalt, and urea)
and to adjust for differences between factories. In this analysis, the relative risk
trend with increasing cumulative respirable fibre exposure strengthened: the
relative risks were 1, 0.46, 0.33, 0.50.
For non-malignant respiratory disease, excluding influenza and pneumonia, the
authors reported for the N-cohort that there was “no consistent evidence of a
positive association with any of the exposure measures considered”.
Because of the lack of exposure data, the relative risk analyses for the O-cohort
used duration of employment as a surrogate measure of exposure. The analysis
adjusted for smoking gave relative risks by increasing duration of employment of
1, 1.82, 0.33 and 0.73, based on 18 cases and 31 controls. The first two relative
risks are for the “short-term workers” and the lower values are for those employed
five or more years.
4.2.3 Case-control studies: European stone/slag wool producers
Boffetta et al (2000), Kjærheim et al (2001, 2002) set up a nested case-control
study within the IARC-coordinated cohort study (see section 4.1.1), but limited to
stone/slag wool producers, being the group which showed evidence of a raised
lung cancer rate. In their report on the cohort mortality study, Boffetta et al (1995)
concluded that
“the issue of confounding by tobacco smoking and other occupational expo-
sures should now be addressed, combined with an as accurate as possible
assessment of past individual exposures to respirable fibres, in a case-
control analysis nested in the [stone/slag wool] subcohort”.
The lung cancer cases reported in the cancer incidence study (Boffetta et al, 1999)
were those selected for the case-control study, excluding 46 cases that occurred
before 1971. The follow-up was extended to 1996 in Denmark, giving a total of
196 cases of lung cancer.
First, each lung cancer case was matched individually with two series of
controls. In the first control series, for each case there were up to four controls
selected, being alive at time of diagnosis of the case but deceased at study time,
and matched as closely as possible on date of birth, limited to within three years,
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and matched on factory (or on country for Norway where the factories were
small). In the second series of controls, each case was matched to up to three
controls as in series I, except that the control did not need to be deceased at the
date of study.
Before proceeding with the full study, a feasibility study was conducted of the
multi-lingual questionnaire designed specifically to gather life-style information
and working history outside the MMVF production industry. Hansen et al (1997)
concluded
“In general, the quality of information obtained from relatives appeared
good. However, information on specific occupational exposures may be im-
proved by supplementing the information from relatives with details
obtained from colleagues, occupational hygiene experts or occupation-
exposure matrices”.
Unlike the University of Pittsburgh study, in the IARC cohort study there were no
individual exposure assessments and factory-based exposure estimates were only
available up to 1977. Hence a primary component of the study was to develop
individual exposure assessments. Expert panels were set up in each factory,
consisting of experienced managers, foremen and workers. Where possible, they
reconstructed the employment and smoking history (job titles, dates, work areas,
work tasks, and tobacco smoking habits) for each case and control. The
information on job tasks was passed to the Institute of Occupational Medicine,
Edinburgh, where hygienists grouped similar jobs. The group list was reviewed by
the Expert Panels who then described the activities and work environment for
each task, in each time period.
Based on this information and knowledge of technological changes in the
factories, individual exposures were assigned to each task, for respirable fibres
and for several possible confounding exposures. These data were then combined
at IARC into exposure indices for each individual. Similar indices were developed
for relevant exposures occurring in other occupations outside MMVF production.
Interviews were completed for 133 cases, all of whom were included in the
analyses, and for 601 controls, of whom 513 were included. Detailed analyses
were conducted using each of the two series of controls, but all results were
effectively the same; so the two control series were combined.
Only two cases (1.5 per cent) had never smoked, compared with 72 (14 per
cent) of the controls. To provide a better baseline for the regression analyses, ex-
smokers who had smoked less than 200 kg of tobacco were included in the
“never/light previous” base-line group.
As expected, the analyses showed highly significant odds ratios, and trends, for
lung cancer with increasing amount smoked. Compared with the base-line group,
the odds ratio for current smokers who had smoked more than 400 kg of tobacco
was 8.8 (95% ci 3.9–19.8). Considering only those employed for more than one
year, this odds ratio was 10.0 (3.4–29.1).
Table 12 shows the odds ratios for some of the exposure indices. For cumu-
lative exposure to respirable fibres, there was a slight downward trend in odds
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ratio with increasing exposure, statistically significantly reduced in the highest
exposure group. For the longer-term workers only, the odds ratio for the second
quartile was increased, based on three lung cancer cases only.
The authors considered it appropriate to consider respirable fibre exposure
lagged by 15 years to allow for the latency between the initial development of the
tumour and consequent death. For this index of lagged cumulative exposure to
respirable fibres, there remained a slight, but less strong, downward trend in odds
ratio with increasing exposure. When this was limited to those who had been
employed for more than one year, the odds ratio for the second quartile was again
increased, also based on small numbers.
Table 12. European Nested Case-Control Study. Stone/slag wool production: Odds ratios
of death from cancer of the trachea, bronchus and lung, for various exposure indices,
adjusted for smoking habits. (Males only. The numbers are shown as cases/controls.)
Quartiles of exposure of all cases
Cumulative exposure to respirable fibres
All workers
Case/Ctrl
OR
95% ci
33/100
1
reference value
32/107
0.86
0.47–1.56
33/111
0.91
0.51–1.63
34/191
0.51
0.28_0.93
Workers
employed
> 1 year
Case/Ctrl
OR
95% ci
12/42
1
reference value
3/12
2.08
0.36–11.91
26/92
0.85
0.34–2.15
34/188
0.52
0.21_1.30
Cumulative exposure to respirable fibres, lagged 15 years
All workers
Case/Ctrl
OR
95% ci
36/115
1
reference value
36/111
1.25
0.66–2.34
30/108
1.02
0.54–1.93
30/174
0.67
0.35–1.27
Workers
employed
> 1 year
Case/Ctrl
OR
95% ci
23/76
1
reference value
3/92
2.00
0.41–9.83
18/69
0.76
0.27–2.17
29/167
0.63
0.28–1.42
Approximate tertiles of exposure
Cumulative asbestos exposure, lagged 15 years
All workers
Case/Ctrl
OR
95% ci
49/175
1
reference value
11/52
2.15
0.61–7.60
11/79
1.13
0.34–3.83
Workers
employed
> 1 year
Case/Ctrl
OR
95% ci
25/120
1
reference value
9/34
2.44
0.59–10.12
10/76
1.09
0.25–4.77
Cumulative exposure to silica, lagged 15 years
All workers
Case/Ctrl
OR
95% ci
69/246
1
reference value
8/13
2.49
0.86–7.14
9/44
0.96
0.38–2.41
Workers
employed
> 1 year
Case/Ctrl
OR
95% ci
39/164
1
reference value
6/12
2.08
0.67–6.46
9/37
1.12
0.42–2.98
From: Kjærheim et al (2001); Boffetta et al (2000).
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Table 12 also shows the pattern of odds ratio for cumulative asbestos and silica
exposures, also with exposure lagged 15 years. For asbestos, there was a slight
upward irregular trend whether based on all workers or those employed in the
production industry for more than one year. The pattern for silica was very similar
to that for asbestos. For PAH exposure, lagged 15 years, the highest exposed
group had the lowest odds ratio. For the other indices of exposure (welding fumes,
arsenic, formaldehyde, and various exposure outside MMVF production) there
were no statistically significant patterns. The highest odds ratio was 4.5 (95% ci
0.7–29.5) for those ever exposed to arsenic among the longer-term workers.
Kjærheim et al (2001) concluded that “This study provides no evidence of a
carcinogenic effect of [stone/slag wool exposure] on the lung under exposure
conditions as experienced in the production industry during the last decades”. The
conclusion from Kjærheim et al (2002) was almost identical:
“This study provides no evidence of a carcinogenic effect of rock and slag
wool on the lung under exposure circumstances in the production industry
during the last four to five decades”.
4.2.4 Case-control studies: US fibrous glass producers
Chiazze et al (1992, 1993, 1995) undertook a case-control study of respiratory
disease in the largest US factory in the University of Pittsburgh studies. The study
population was as defined by Enterline et al (1987). The company undertook an
historical environment reconstruction, from which a database of task-based
exposure to various environmental substances was developed. Demographic
information, occupational history, smoking history, residence, hobbies and
medical history were collected using a questionnaire designed for response by an
individual or by a proxy.
There were 166 cases with lung cancer, and 112 cases with non-malignant
respiratory disease. These were matched to 406 and 270 controls respectively. It
proved impossible to interview several people, so that there were 144 and 102
cases available for analysis with their 299 and 201 controls.
For lung cancer, univariate analyses showed significant associations of risk
with various indices of tobacco smoking. For example, the odds ratio for those
who had smoked less than 40 pack-years was 10.4 (95% ci 1.3–81.6), and for the
heavier smokers it was 13.9 (1.8–106.4). There was also evidence that those with
the longest period of education had the lowest lung cancer risk.
Analysis of risk related to exposure indices showed that those first hired before
1945 had twice the risk of those hired later. Otherwise there was no association of
lung cancer risk with duration of employment, age when first hired, or cumulative
exposure to airborne respirable fibre, asbestos, talc, formaldehyde, respirable
silica, asphalt fumes or total particulates. When the odds ratio analyses were
adjusted for tobacco smoking, the odds ratio for lung cancer of ever having
smoked was 26.2 (95% ci 3.3–206.5). The only other statistically significant
finding was a lower odds ratio for those with longer periods of education. For
cumulative respirable fibre, talc and respirable silica, the pattern of odds ratio was
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irregular, but with no significantly raised risks. For asbestos and formaldehyde,
the trend was for decreasing risk with increasing exposure. Those with any
exposure to asphalt fumes had an odds ratio of 1.13.
For non-malignant respiratory disease, there was a smaller, but still statistically
significant effect of tobacco smoking. The odds ratio for those who had smoked
less than 40 pack-years was 1.9 (95% ci 0.4–10.0), and for the heavier smokers it
was 9.4 (1.2–74.5). There was no other non-exposure index showing a relation of
disease risk.
The multivariate analyses showed that the non-malignant respiratory disease
odds ratio for the ever smokers was 2.6 (95% ci 1.1–6.1). No other demographic
or exposure variable showed a significant association. However, the disease risks
relative to those not exposed to respirable silica all exceeded 2.2 and the results
are suggestive of an adverse effect. Also the odds ratios for the highest exposure
levels of respirable glass fibres, asbestos and asphalt fumes are all raised, even
though non-significantly.
Chiazze et al (1999) also specifically investigated mortality from nephritis and
nephrosis, using data from the occupational health surveillance programme of the
largest US producer of fibrous glass products. There were 15 deaths with under-
lying cause of nephritis or nephrosis, and a further 36 with nephritis or nephrosis
listed as a contributory cause of death. These cases were matched by year of birth,
factory and survival, giving 48 controls for the primary cases, and 172 controls for
the full series.
This study was particularly addressed towards questions posed by Goldsmith
and Goldsmith (1993); they had suggested that an excess of nephritis or nephrosis
could be related to respirable silica exposure among MMVF production workers.
Hence, Chiazze et al specifically studied nephritis and/or nephrosis in relation to
estimates of cumulative respirable fibre exposures and of cumulative respirable
silica exposures. These estimates were determined from the company’s associated
historical environmental reconstruction database. Socio-demographic information
was collected by interview.
For the analyses of the cases with nephritis or nephrosis as an underlying cause
of death, the paucity of data means that the confidence intervals were very wide,
and the analyses essentially uninformative. Based on the combined series of cases
(underlying and contributory causes), case-control analyses showed a downward
trend in odds ratio with increasing exposure to respirable fibres, no association
with cumulative silica exposure and no association with education level, marital
status, income level, tobacco smoking or alcohol consumption.
The authors conclude that it is appropriate to consider contributory as well as
underlying cause of death. They also stated
“Although these results do not prove that there is no association between
nephritis or nephrosis and exposure to fibreglass or silica [...] they do not
support the assertion that such an association exists”.
Marsh et al (2001) nested a case-control study of fibrous glass producers within
the cohort study considered in sections 4.1.5 and 4.1.6 above. The cases were all
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716 male deaths from respiratory system cancer during the period 1970-1992. For
each case, one control was selected born within one month of the case and alive at
the date of death of the case. Cases were not matched by race or factory.
Tobacco smoking information was collected for each case and control, using a
structured questionnaire administered by telephone with the person himself, or
with someone who knew the person. This was usually a family member. Smoking
information was available for more than 80 per cent of the cases and the controls.
Interview records were available for 502 case-control pairs. To maximise the size
of the database, unmatched cases and controls were combined with closely
matched pairs, or to form additional matched sets, resulting in 519 matched sets of
cases and controls for statistical analysis.
As expected, tobacco smoking was a highly significant predictor of respiratory
cancer mortality. Compared with the never-smokers, the odds ratio for ever-
smokers was 13.1 (95% ci 7.0–24.3). Unadjusted for tobacco smoking, the
respiratory cancer odds ratio showed a slight downward trend with increasing
duration of employment, concordant with the findings that the short-term workers
had higher SMRs for respiratory system cancer. There was no trend of odds ratio
with years since first employment.
Adjusted for smoking, the odds ratios for lung cancer showed no trend with
increasing cumulative respirable fibres. For deciles of exposure, the odds ratios
were 1 (reference value), 1.39, 0.95, 1.28, 1.30, 0.79, 0.96, 1.57, 1.24 and 1.18.
None of these odds ratios was significantly more or less than unity. When the
results were cross-tabulated by duration and average intensity of exposure to
respirable fibres, there was some indication of an increasing odds ratio with
increasing intensity of exposure. However, none of the odds ratios was signifi-
cantly raised above unity.
Considering co-exposures, there was no evidence in this case-control study of
an association between respiratory system cancer and exposure to arsenic,
asbestos, asphalt, epoxy, PAHs, silica, styrene, urea or phenolics. For formalde-
hyde, there were non-significant trends of increasing odds ratio with years of
exposure, average intensity of exposure and cumulative exposure. Some of the
individual odds ratios were significantly raised above unity.
The authors concluded that
“Our case-control findings to date suggest that duration and exposure to
respirable fiber glass at the levels encountered at the study plants are not
associated with an increased risk for [respiratory system cancer]”.
This conclusion applied with or without adjustment for tobacco smoking, plant
and several co-exposures.
4.2.5 Case-control studies: US continuous glass filament producers
Chiazze et al (1997) used similar methodologies to those described in their case-
control studies of fibrous glass workers (section 4.2.4). For these glass filament
producers, there was no evidence of any association between exposure to respir-
able glass fibres, refractory ceramic fibres, respirable silica, asbestos, total chrome
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or arsenic. The authors concluded that none of the exposure indices was associ-
ated with an increase in lung cancer risk for this population.
4.3 Additional evidence from other epidemiology
Kjuus et al (1986) carried out a case-control study of lung cancer in south-east
Norway. In this study the authors examined the relationship between lung cancer
and occupational exposures as well as smoking in 176 male lung cancer patients
and their matched controls between 1979 and 1983. Heavy smokers were found to
have a lung cancer odds ratio of 32-fold. The investigators also analysed the data
by occupational exposures, including rock and glass fibres. The authors reported
an odds ratio of 1.2 for workers with such exposures without adjustment for
tobacco smoking. However, when the analysis was adjusted for smoking, the odds
ratio became 1.0 (95% ci: 0.4–2.5).
Brüske-Hohlfeld et al (2000) pooled two German case-control studies to search
for associations between lung cancer risk and occupation. These studies were a
matched case-control study of lung cancer and occupational risk factors, and a
frequency-matched case-control study to study the impact of radon exposure on
lung cancer risk. There was no discussion of the effect of pooling studies of
different design.
Smoking, demographic and occupational histories were collected using a
standardized questionnaire and the occupations were grouped by industry into 21
categories and by job title into 33 categories. Cumulative exposures were assessed
using job exposure matrices for silica and PAHs, by written description for diesel
exhaust, by written description and supplementary questionnaire for MMVF and
by semi-automatic quantification for asbestos, with 17 job-specific supplementary
questionnaires. For MMVF, the supplementary questionnaire asked “insulation
installers and electrical and electronic fitters [...] whether they had installed or
removed insulation and what kind of insulation material they had used”.
There were 3,498 male cases and 3,541 controls. There was the expected
strong association with tobacco smoking, with 1.5 per cent of cases and 17.4 per
cent of controls being lifelong non-smokers. Using the self-reported exposures to
MMVF, the authors found significantly raised lung cancer risks, adjusted for
tobacco smoking and asbestos exposure (odds ratio 1.5, 95% ci 1.2–1.9), based on
304 cases and 170 controls who reported that they had worked with MMVF. The
adjusted odds ratio was 2.0 for those exposed for more than 30 years.
The findings in relation to MMVF exposure have been published in more detail
by Pohlabeln et al (2000). The numbers of subjects and the odds ratios are identi-
cal. However, this report describes two additional questionnaires for the assess-
ment of MMVF exposure. Each questionnaire asked specifically whether they
used glass or mineral wool fibres. It must be assumed that the same workers
(construction industry insulation installers, removers; electrical and electronic
fitters) were asked supplementary questions about asbestos exposure, although
that is not stated in these reports.
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This report also describes the estimation of MMVF exposure indices for a
subset of 59 cases and 39 controls, who self-reported no exposure to asbestos. The
median MMVF exposure was lower among the cases than among the controls (0.4
vs 0.5 MMVF fibre.years). The lower and upper quartiles were almost identical,
but the mean for the cases was twice that for the controls (2.52 vs 1.21 fibre.
years). Above the 90th percentile for MMVF exposure there were eight cases and
two controls. These proportions do not differ significantly, and a Wilcoxon rank-
sum test showed no difference between cases and controls (P=0.83).
Given the similarities in these distributions of exposures, it is very difficult to
understand how the mean exposures were so different. A rough calculation
suggests that there must have been three or four cases with exposure levels of the
order of 25-30 MMVF fibre.years. It would be interesting to know the occupa-
tions of these few individuals.
Sub-dividing this group into two sub-groups on the basis of MMVF exposure
yields odds ratios which are lower for the higher exposure group. None of the
odds ratios for the group reporting only MMVF exposure are significantly raised
above unity, although all three are raised.
These two publications do not discuss the extent to which self-reporting of
exposures under-estimates exposure to asbestos. These results are in contrast with
those of Engholm et al (1987) for Swedish construction workers, who also used
self-reporting of exposures to asbestos and to MMVF. Engholm et al (1987) noted
“that subjects in the cohort to some extent are unaware of their exposure to
asbestos”. Indeed 21 out of the 23 pleural mesothelioma cases did not self-report
exposure to asbestos, yet it must be reasonable to assume that most of these were
caused by asbestos exposure.
Rödelsperger et al (2001) described a case-control study comparing 125 male
mesothelioma cases with the same number of matched population controls. The
interviews were described as similar for the two groups. There was the expected
very strong relation between exposure to asbestos and mesothelioma.
For MMVF, there was a significant association between mesothelioma risk and
exposure. However, this became non-significant statistically when adjusted for
exposure to asbestos. There were just two cases and two controls who were repor-
ted to have had exposure to MMVF, but not to asbestos. The authors commented
“This observation is heavily hampered by methodological problems” [and]
“A causal relationship between exposure to MMVF and mesothelioma could
neither be detected nor excluded”.
Marchand et al (2000) used the data from a French case-control study to assess the
relation between laryngeal and hypopharyngeal cancer and exposure to asbestos
and MMVF. The 528 cases were all newly diagnosed with squamous cell
carcinoma of the larynx or hypopharynx between 1989 and 1991. There were 305
controls who were patients in the same hospitals with a non-respiratory cancer.
A detailed job history was recorded, as was information on tobacco smoking
and alcohol consumption. A job-exposure matrix was used to estimate exposure to
asbestos and to four types of MMVF: mineral wools; refractory ceramic fibres,
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glass filaments and microfibres. It must be presumed that “mineral wools” in-
cluded glass wool as well as stone/slag wool. The job-exposure matrix provided
for each task both probability and intensity of exposure.
Without making any adjustments for tobacco smoking or alcohol consumption,
the authors reported a raised odds ratio for laryngeal cancer for exposure to
asbestos, and significantly raised odds ratios for hypopharyngeal and epilaryngeal
cancer. The odds ratios were 1.80 (95% ci 1.08–2.99) and 2.22 (1.05–4.71)
respectively. For mineral wool exposure, the odds ratio was also highest for
epilaryngeal cancer (OR 1.85; 95% ci 1.08–3.17), and raised for hypopharyngeal
and laryngeal cancer. When analyses included both asbestos and mineral wool
exposures, all the odds ratios reduced.
For asbestos exposure, an analysis standardised for cigarette smoking showed
approximately a four-fold risk related to higher smoking and about a 1.5-fold risk
for higher asbestos exposure. No such analysis was reported for mineral wool
exposures, nor were there analyses including alcohol consumption.
Only four cases and 1 control were assessed as having mineral wool exposure
but not asbestos exposure. The authors concluded that the results “may also
suggest that mineral wools may have a carcinogenic effect on the epilarynx and
the hypopharynx, but the possibility of a confounding by asbestos exposure
requires that these findings be interpreted cautiously”, especially as so many
mineral wool exposed people had previously been exposed to asbestos.
5. The IARC review of the health effects of MMVF, 2001
As discussed above, considerable new evidence on the carcinogenicity of MMVF
had been published in the dozen years since the IARC Working Group on the
Hazard Assessment of MMVF meeting in 1987.
By the end of the year 2000, it was clear that the two major studies, in Europe
and in USA, were both going to publish results indicating lack of evidence of lung
cancer risk from exposure to MMVF in MMVF production. When IARC pub-
lished their Internal Report No. 00/004 (Boffetta et al, 2000), the IARC
Collaborators in Norway and Denmark issued press releases on the results,
highlighting the contributions of their scientists to the IARC-coordinated studies.
The press release from The Cancer Register of Norway (2000) stated
“The earlier suspicion that mineral wool fibres can cause lung cancer was
not confirmed in a new European study by WHO’s International Agency for
Research on Cancer in Lyon (IARC). The study shows that mineral wool
fibres do not give rise to lung cancer in the workers in the Rockwool
factories. The results are based on an extensive international investigation
with participation of Denmark, Sweden, Germany and Norway”.
The Danish Cancer Registry (2000) commented
“The suspicion from earlier studies of mineral wool fibres as the cause of
lung cancer cannot be confirmed among European Rockwool workers,
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[adding] Perhaps surprisingly, the cause of cancer is presumably not to be
found in the mineral fibres, but on the contrary possibly in the effects of the
rest of the working environment and smoking”.
Thus, the scene was again painted for the formal reviews of hazard, by IARC in
2001, but the scene was rather different from that in 1987.
5.1 IARC Evaluation of Carcinogenic Hazard, 2001
As discussed in section 3.1, IARC convened a Working Group in June 1987 to
consider the hazard classification for the carcinogenicity of MMVF and of Radon
(IARC, 1988). A further Working Group was convened in October 2001 to
reconsider the hazard classification of MMVF, particularly to take into account
the research conducted since 1987, not just in epidemiology, but also in experi-
mental studies. The understanding of the roles of biosolubility and fibre size in the
retention kinetics of MMVF has also proved important for hazard assessment.
For the October 2001 meeting, IARC appointed an expert panel of 19 scientists
from the field of fibre science and epidemiology to review the updated scientific
information (IARC, 2002). There were also five observers present, including the
present author, but we did not take part in evaluating the evidence. The evaluation
is summarised in Table 13.
On the human carcinogenicity data, the experts concluded that:
“Results from the most recent cohort and nested case-control studies of US
workers exposed to glass wool and continuous glass filament and of
European workers exposed to rock (stone) and slag wool have not provided
consistent evidence of an association between exposure to fibres and risk for
lung cancer or mesothelioma.
These studies, like all epidemiological investigations, have limitations
that must be borne in mind when interpreting their results. Although the
exposure assessment methods used in these studies are far better than in
most epidemiological studies, there is still the potential for exposure mis-
classification. Notably these studies were not able to examine fully the risks
to workers exposed to more durable fibres. Information on smoking and on
the other potential confounders that were adjusted for in these studies are
also subject to measurement error, which may have influenced the validity
of the adjustments made for these factors.
Underascertainment and misclassification of mesothelioma may also be a
concern in these studies, which primarily relied upon death certificate
information. Finally, although these studies are very large by epidemio-
logical standards, their sensitivity may be limited by the fact that fibre
exposure levels were low for a large proportion of the study population.”
Given these conclusions, based on the same research as reviewed in section 4
above, the IARC experts’ evaluation was that “There is inadequate evidence in
humans for the carcinogenicity” of each of the MMVF fibre types.
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Table 13. IARC (2002) Classification for the carcinogenicity of MMVF
Man-Made Vitreous Fibres
Evaluation
Special-purpose
glass fibres
Insulation glass
wool
Continuous glass
filament
Rock (stone) wool
Slag wool
Refractory
ceramic fibres
Human carcinogenicity
“There is in-
adequate evidence
in humans for the
carcinogenicity of
special-purpose
glass fibres”
“There is in-
adequate evidence
in humans for the
carcinogenicity of
insulation glass
wool”
“There is in-
adequate evidence
in humans for the
carcinogenicity of
continuous glass
filament”
“There is in-
adequate evidence
in humans for the
carcinogenicity of
rock (stone)
wool/slag wool”
“There is in-
adequate evidence
in humans for the
carcinogenicity of
refractory ceramic
fibres”
Animal carcinogenicity
“There is suffi-
cient evidence in
experimental
animals for the
carcinogenicity of
special-purpose
glass fibres”
“There is limited
evidence in
experimental
animals for the
carcinogenicity of
insulation glass
wool”
“There is in-
adequate evidence
in experimental
animals for the
carcinogenicity of
continuous glass
filament”
“There is limited
evidence in
experimental
animals for the
carcinogenicity of
rock (stone) wool
and of slag wool”
“There is suffi-
cient evidence in
experimental
animals for the
carcinogenicity of
refractory ceramic
fibres”
Overall Evaluation
2B 3 3 3 2B
Possibly carcino-
genic to humans
Not classifiable as
to their carcino-
genicity to humans
Not classifiable as
to their carcino-
genicity to humans
Not classifiable as
to their carcino-
genicity to humans
Possibly carcino-
genic to humans
Note: The working group also considered that there was inadequate evidence in experimental
animals for the carcinogenicity of “certain newly-developed, less biopersistent fibres”. How-
ever, no Overall Evaluation was made for these fibres.
Extracted from: International Agency for Research on Cancer. IARC monographs on the
evaluation of the carcinogenic risks of humans. Man-made vitreous fibres, vol 81, 2002.
The summary of the evaluation (Table 13) shows that, for carcinogenicity in
experimental animals, there were differing assessments by fibre product group. In
particular, for the two most common groups, insulation glass fibres and rock
(stone) and slag wool, the evaluation was “There is limited evidence in experi-
mental animals” for their carcinogenicity. This was unchanged from the 1987
evaluation of rock (stone) and slag wool, but a lesser evaluation for glass wool.
However, in the 1987 evaluation, glass wool and the special-purpose fine fibres
were considered as one group; in the 2001 evaluation special-purpose fine fibres
were considered separately and evaluated as “sufficient evidence for carcino-
genicity in experimental animals”.
6. Comments and conclusions
The second half of these twenty-five years of epidemiological research has largely
reversed the first half. Initially there was no evidence of disease, as few human
studies had been conducted. But by the time of the IARC and IPCS reviews in
1988, there was justifiable concern that stone/slag wool fibres might be carcino-
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genic to humans by inhalation. In IARC’s language, for stone/slag wool: “There is
limited evidence for carcinogenicity to humans”. This interpretation remained
reasonable with the results of the continued cohort studies over the next decade.
However, the nested case-control studies have shown little evidence of any
lung cancer risk to MMVF production workers. Given that these studies used
analyses adjusted for tobacco smoking, unlike the cohort studies, the case-control
study conclusions should carry most weight in the assessment of the hazard and
risk of exposure to airborne respirable fibres.
Yet, the apparently different conclusions of cohort and nested case-control
studies need explanation and resolution. Social class effects, particularly tobacco
smoking, are most relevant. The cohort approach uses mortality rates for all
people in the reference population to calculate the expected number of deaths.
Logan (1982) has shown higher age-specific total and lung cancer mortality rates
for blue collar workers, with increasing differentials for lung cancer over time.
The US Surgeon-General reported similarly (U.S. Department of Health and
Human Services, 1985) and estimated that a 20 per cent higher prevalence of
cigarette smoking was associated with a 20 per cent increase in mortality rates for
lung cancer. Axelson (1978, 1989) has also estimated how much differences in
smoking prevalences could affect mortality rates, concluding that “confounding
from smoking would rarely explain risk ratios of more than about 1.5 for lung
cancer”.
The Copenhagen Male Study (Hein et al, 1992) on “Lung cancer risk and
social class” showed that the lung cancer relative risk for blue collar workers
decreased by just over 20 per cent when adjusted for tobacco smoking habits.
They also recorded that the smoking adjustment did not account for more than
about one-third of the social class differences in lung cancer mortality rates.
Thus, if a group of workers smokes more heavily than the national or regional
average, then standardised mortality ratios for lung cancer will be higher by about
20 to 40 per cent, just because of the comparison with the national or regional
population. The nested case-control approach avoids that bias, as the comparisons
are like with like, in terms of socio-economic status. Thus it is unsurprising to
have raised lung cancer SMRs for a heavily-smoking cohort, but no raised odds
ratios or relative risks in the nested case-control studies.
Marsh et al (2002) reviewed their studies in North America to ask “Does fiber
glass pose a respiratory system cancer risk in humans?”. Much of the discussion
considered the impact of tobacco smoking on the interpretation of the results. The
authors concluded that the raised SMR for respiratory system cancer among male
workers “appears to be entirely explained by positive confounding [of fibre
exposure indices] by smoking”.
Kjærheim et al (2001) reported that the controls in the IARC case-control study
had a 20 per cent raised prevalence of ever tobacco smoking. There was a greater
excess of ever-smoking among the workers in the University of Pittsburgh study
(Buchanich et al, 2001). Standardised for the different numbers in each factory,
male fibrous glass production workers with known smoking history at 1 January
1980 had a point prevalence of 75.7 per cent for ever-smoking, compared to a rate
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of 51.0 per cent expected based on the local State smoking rates on the same date.
For mineral wool producers, the ever-smoking point prevalence was similarly
raised about 1.5 fold (73.8 vs 47.6 per cent).
Chiazze et al (1995) reviewed specifically lung cancer mortality in the largest
of the US fibre glass production factories. The prevalence of ever having smoked
tobacco among the production workers was 12 per cent higher than the US Male
prevalence, adjusted to the same age distribution. Based on this difference in
prevalence of ever smoking tobacco, the authors concluded that the smoking-
adjusted lung cancer SMR was 107.8, 90 per cent of the unadjusted SMR of
119.6.
Wong and Musselman (1994) reported an extended analysis of their stone/slag
wool case-control study (Wong et al, 1991). They estimated the increased risk due
to coexposures, for various values of lung cancer relative risk and proportions of
smokers in the exposed and comparison populations. For a relative risk of 5 for
smoking, and smoking proportions of 0.7 in the exposed and 0.5 in the compa-
rison populations, then the increased risk is 27 per cent. They concluded that “the
modest increase in lung cancer reported previously in cohort studies of MMVF
workers could easily be explained by a 20 per cent difference in smoking preva-
lence”.
The combined case-control study reported by Brüske-Hohlfeld et al (2000) and
by Pohlabeln et al (2000) did also include assessment of smoking habits. The
results from this population-based study are somewhat more suggestive of an
increased risk of lung cancer from exposure to MMVF. But the authors them-
selves have commented on the inadequacies of their studies, and did not conclude
that there was evidence of causation.
In conclusion, in the two major cohort studies, the workers had a higher pro-
portion of tobacco smokers than the national or regional comparison populations.
In particular, the ever-smoking rate is higher by between ten and 50 per cent.
These differences in tobacco smoking rates alone are large enough to account for
the raised lung cancer mortality rates reported in the cohort studies, making the
findings fully compatible with those of the case-control studies which have found
no evidence of any lung cancer risk for these workers.
Thus, after 25 years of epidemiology, the conclusion should come back to its
original state: there is no adequate evidence of an adverse risk, but today that
conclusion is based on the results from well-conducted and extensive epidemio-
logical research.
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7. Summary
Rossiter Charles E. (2002) Man-Made Vitreous Fibres. 25 years of epidemiolo-
gical research on mortality and cancer incidence. Arbete och Hälsa 2002:14,
National Institute for Working Life, Stockholm.
An intensive study of the possible adverse health effects of fibre glass and
stone/slag insulation wools has taken place over the last 25 years. This review
concentrates on the epidemiological research, particularly as it bears on lung
cancer mortality and incidence. It also considers how the scientific evidence has
affected public and regulatory opinion.
There have been two major cohort studies, one in Europe coordinated by The
International Agency for Research on Cancer (IARC) and the other in USA,
coordinated by the University of Pittsburgh. Each of these populations has been
followed up three times, and case-control studies have been nested within the
cohort studies. Several other cohort and case-control studies are also reviewed.
The trigger for this research programme was that in 1972, two studies were
published reporting that implantation of fibres into the pleural or peritoneal
cavities of rats produced mesothelial tumours. The production industry responded
by funding independent epidemiological, animal experimental, and environmental
research, which has continued for the last 25 years.
The cohort studies produced evidence suggestive of a possible lung cancer
hazard among the insulation wool production workers. The strength of the
evidence appeared to increase with continued follow-up. In 1988, IARC con-
sidered the evidence on rock and slag production workers to provide limited
evidence of carcinogenicity, while the evidence on glass production workers was
considered inadequate. When combined with the data on animal studies, especi-
ally the studies in which fibres were injected or implanted directly into the
animals, IARC classified these insulation wools as possibly carcinogenic in
humans. This was followed by increasing public concern and regulatory activity
in many countries.
The cohort studies have been consistent in showing a raised Standardized
Mortality Ratio (SMR), more so for the stone/slag wool producers. Even so, the
evidence has never been reported by any of the cohort study authors as strong
enough to conclude that a causal effect of fibre exposure existed. Yet, the case-
control studies of production workers have produced little evidence of an adverse
risk to exposed workers. These include the case-control studies nested within the
major cohort studies; the results from the two study designs need resolution.
Subsequently, in 2001, IARC reviewed the latest evidence on the hazard of
exposure to MMVF and classified the insulation wools produced from glass, rock
and slag as “Not classifiable as to their carcinogenicity to humans” (Category 3).
On the epidemiological evidence, the conclusion was that there is inadequate
evidence in humans for the carcinogenicity of any of the MMVF.
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It is postulated in this review that the resolution of these differences lies in
large part in the smoking histories of the production workers. The prevalence of
ever-smoking tobacco was 10 to 50 per cent higher among the production workers
than among the national or regional populations used to calculate the SMRs.
These higher smoking rates are enough to account for the higher risks estimated
from the cohort studies. This is also the conclusion of the epidemiological experts
on the IARC review.
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8 Summary in Swedish
Charles E. Rossiter: Man-Made Vitreous fibres – 25 years of epidemiological
research on mortality and cancer incidence. Arbete och Hälsa 2002:14, Arbets-
livsinstitutet, Stockholm.
Frågan om oönskade hälsoeffekter av inandade mineralfibrer har ägnats stor upp-
märksamhet under de senaste 25 åren. Denna litteraturgenomgång inriktas mot de
epidemiologiska undersökningar av exponering för fibrer härrörande från glas-
och sten/slaggmaterial som utförts och publicerats under denna tid. Den viktiga
frågan har gällt fibrernas cancerframkallande egenskaper. I rapporten kommen-
teras också den påverkan som publicerat material och den härtill hörande veten-
skapliga diskussionen har haft på den allmänna opinionen och på tillsynsmyndig-
heters förhållningssätt i dessa frågor.
Frågan om mineralfibrernas cancerframkallande egenskaper kom att uppmärk-
sammas stort 1972 då två studier publicerades med rapporter om att mineralfibrer
injicerade i bukhåla eller lungsäck hos försöksdjur framkallade elakartade mesote-
liala tumörer, sk mesoteliom. Mineralfiberindustrins reaktion på detta var att
initiera epidemiologiska studier, djurexperimentella undersökningar och miljö-
kartläggningar utförda av i förhållande till industrin oberoende forskargrupper.
Rapporten följer framför allt två stora epidemiologiska undersökningar, den
ena utförd i Europa – ledd och koordinerad av det internationella cancerforsk-
ningsinstitutet IARC (International Agency for Research on Cancer), Frankrike
och den andra utförd i USA vid universitetet i Pittsburgh. Dessa undersökningar
av stora kohorter har vardera följts upp vid tre tillfällen och även kompletterats
med sk fall-referentstudier. Några andra i sammanhanget viktiga kohortstudier
kommenteras också i rapporten.
Inledningsvis resulterade analyser av de stora kohortstudierna indikationer på
ett tänkbart samband mellan exponering för fibrer av mineralull i tillverknings-
industrin. Risktalet föreföll öka vid förlängning av observationstiden. IARC
utförde år 1988 en granskning av tillgänglig vetenskaplig bevisning och bedömde
att i fråga om sten/slaggull fanns vissa indikationer på möjlig cancerrisk.
Beträffande fibrer av glasull tillät det epidemiologiska bevismaterialet ingen sådan
bedömning. Då IARC tog med i bedömningen djurexperimentella resultat från
tester där fibrerna injicerats direkt i andningsvägar, bukhåla eller lungsäck blev
slutsatsen då att fibrernas kancerframkallande egenskaper var möjlig (”possibly
carcinogenic”).
I de fortsatta uppföljningarna av de stora kohortmaterialen har de höjda död-
lighetstalen (SMR) för anställda i sten/slaggullsindustri blivit kvar på samma nivå.
Trots detta har de forskargrupper som svarat för undersökningarna inte tolkat
iakttagelsen som varande ett orsakssamband. Bevisningen för detta bedömdes som
otillräcklig. De fall-referentstudier som utfördes både i Europa och i USA gav inte
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resultat som bekräftade eller styrkte misstanken om cancerframkallande egenskap
hos de undersökta fibrerna.
IARC sammankallade en expertgrupp år 2001 för att återigen gå igenom till-
gängligt bevismaterial i frågan om mineralfibrer och cancerrisk vilket ledde till
bedömningen att isoleringsull av glas, sten och slagg inte var klassifierbara som
cancerframkallande för människa (”not classifiable as to their carcinogenicity to
humans). De hänfördes därför till IARC cancerklass kategori 3. Detta innebar en
väsentligt mindre sträng bedömning än den som gjorts vid IARC granskning
1988.
Författaren lanserar i rapporten sin tolkning att de förhöjda risktalen för
dödlighet och förekomst av lungcancer är till stor del att tillskriva tobakskonsum-
tionen i de undersökta kohorterna. Den var enligt författaren på tio till 50 procent
högre nivå än i den allmänbefolkning som utgjorde jämförelsebas i beräkningarna
av dödlighetstalen (SMR). Denna tolkning överensstämmer också med de bedöm-
ningar som gjordes av den epidemiologiska expertis som deltog i denna nya IARC
genomgång.
IARC granskningsrapport av 2001 återfinns i litteraturförteckningen.
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